{
    "id": "kvovdtavsm43o4s2coo3xgpf2yaitpxa",
    "title": "Graphical Models for HIV Vaccine Design",
    "info": {
        "author": [
            "David Heckerman, Microsoft Research"
        ],
        "published": "June 22, 2007",
        "recorded": "June 2007",
        "category": [
            "Top->Computer Science->Machine Learning->Graphical Models"
        ]
    },
    "url": "http://videolectures.net/icml07_heckerman_gmhi/",
    "segmentation": [
        [
            "Machine learning an applied statistics group at Microsoft Research.",
            "I David is one of my heroes in machine learning, I think exemplifies.",
            "The kind of excellent person that is attracted to work in this area by bringing together both really deep understanding of the theoretical and mathematical foundations of the field with a tremendous commitment to doing applied research.",
            "And this goes back a long way actually before he was doing anything related to learning at all, he got an MD and PhD at Stanford because he was committed to trying to do artificial intelligence and decision science in.",
            "In medicine, but then you know the attraction of actually learning from data grip him.",
            "He's worked on all kinds of different things at Microsoft Research, data mining, product, large scale DM lots, and lots of variations on decision theory.",
            "Of course, he's worked on diagnosis, so there are several components in at least this box you know that have to have that bear his fingerprints.",
            "So without further ado, let me introduce David Heckerman who's talking about yet another.",
            "Make progress with HIV.",
            "Next time, thank you.",
            "Thank you, it's a pleasure to be here.",
            "I would like to thank the organizers for inviting me and I'd like to thank you all for hanging in there to the end.",
            "This is for the camera.",
            "Is this an hello?",
            "Oh, OK, I'll do the.",
            "I'll do the nightclub routine here is this working.",
            "OK, very good, alright well.",
            "How about three or four years ago I came onto this problem of HIV vaccine design and it had some interesting success and it brought me into discussions with lots of HIV researchers, and I began to listen to them understand their problems and found a couple of really interesting applications of graphical models that at least I thought would help them.",
            "And it turns out that it has.",
            "So today I'd like to share those applications with you and also in the process of developing these graphical model applications for HIV vaccine design.",
            "I learned from the biologist I learned that there was something that we were doing with graphical model learning that wasn't satisfying them.",
            "There was a real weakness in graphical model learning, so I identified that and came up with a solution that I'll share with you as well.",
            "And I should say this is not my own work, this is.",
            "Only my work, this is joint work with Charles, Jonathan Carlson, Jennifer Liz, Garton Ann Karl Katie."
        ],
        [
            "All at Microsoft Research.",
            "So I don't think I need to emphasize very much the importance or the need for an HIV vaccine.",
            "HIV and the disease it causes, namely AIDS, is one of the deadliest pandemics in recorded history.",
            "About 10,000 people die per day of AIDS.",
            "Treatments are great.",
            "Now they've come up with some great treatments, but they're very expensive.",
            "And if you miss a few doses, the virus can come back and even a stronger form and kill you very rapidly.",
            "So treatments are great if you live in Europe or the United States.",
            "But they're not good if you live in a developing country and there a vaccine."
        ],
        [
            "It is still the greatest hope.",
            "So what I thought I'd do is first just give you some background in HIV and our immune system which fights HIV.",
            "Then go over these two graphical modeling applications.",
            "Then describe this weakness in graphical model learning that it was alluding to, and then show you a solution we've come up with.",
            "It's based on what's known as the."
        ],
        [
            "False discovery rate.",
            "So HIV is a retrovirus and it uses your own cells to make more of itself.",
            "So basically HIV is a BI lipid particle with a BI lipid membrane with some proteins sticking out of it, an RNA payload.",
            "These proteins help the HIV particle fuse with your own cells membrane when the Fusion happens, the RNA gets out, gets reverse transcribed to DNA, which then makes it into your nucleus.",
            "And then your nucleus produces more RNA, which then produces more HIV proteins.",
            "These proteins and the RNA assemble and butt off from the cell wall, forming many new particles which go off and infect."
        ],
        [
            "Other self now there's two ways our immune system fights HIV an in fact, retroviruses in general, there's two arms of our adaptive immune system.",
            "The humor alarm, which manufacturers antibodies, and these antibodies recognize an neutralize these particles as they are floating freely in your body.",
            "And then there's the cellular arm of the immune system, which uses what are called killer T cells.",
            "This is basically a subset of your white blood cells.",
            "Which identify and destroy your own cells that have been infected, thus producing the virus from."
        ],
        [
            "Reading further.",
            "Now, HIV has been around for about 20 years and people have been trying for these 20 years to build a humoral arm vaccine, a vaccine based on antibodies, and so far they have not met.",
            "Met with success.",
            "There's over 170 trials, I think that have gone on.",
            "None of them have produced or show that a vaccine to be a viable candidate yet.",
            "So more recently, people have been looking at the cellular arm of the immune system for vaccine design, and there there is a fundamental question.",
            "Is the cellular arm of our immune system strong enough to fight HIV and this question?",
            "The answer of this question has been quite controversial.",
            "As you'll see we use graphical models to help."
        ],
        [
            "Answer this question so we're going to focus on the cellular arm of the immune system for this part of the talk, so let me give you a few details about this arm of the immune system.",
            "So as proteins are being manufactured in your cells, some subset of them get chopped up into little bits.",
            "So proteins or strings of amino acids.",
            "These bits tend to be anywhere from 8 to 11 amino acid.",
            "Long strings of amino acids, and they're called epitopes.",
            "And these epitopes bind, which with water called HLA molecules human Lucas."
        ],
        [
            "Light energy and molecules and these HLA molecules transport the epitope to the cell surface.",
            "So they're right there outside the cell, viz."
        ],
        [
            "Two other cells and then a killer T cell can come along.",
            "That's been pre trained to recognize this combination and say ah ha, you're a foreign epitope."
        ],
        [
            "You don't belong there.",
            "I'm going to kill the cell that you're exposed on an in so doing new virus particles can't be manufactured by this cell, any law."
        ],
        [
            "Eager.",
            "OK, so the question here the fundamental question if you're going to design A vaccine for HIV based on the cellular immune system, is is the cellular arm of the immune system effective on HIV is this?"
        ],
        [
            "And then I just showed you effective on HIV.",
            "So to understand how we might answer that question, I need to tell you three things.",
            "The first thing is these HLA molecules.",
            "They are very diverse.",
            "There's three genes that code for HLA molecules in your body.",
            "They're very creatively named the aging.",
            "The BG Nancy Jean and they're very diverse.",
            "There's hundreds of different types of AA, hundreds of different types of bees, hundreds of different types of CS which have two chromosomes.",
            "We get 2 copies of the gene, so we have two as two bees and two seas.",
            "So the chances that any two of us have the same HLA 6 HLA types is very small.",
            "It's like one in 10,000,000.",
            "The second thing you need to know is that this epitope binding in the HLA molecule is very specific.",
            "So what is an epitope for a particular HLA molecule will very likely not be an epitope for another HLA Mal."
        ],
        [
            "Kill.",
            "The third thing you need to know is that HIV mutates very rapidly.",
            "This is the entire map of HIV.",
            "It's amazingly small, it's only HIV is only 3000 amino acids long, and these are the proteins that get coded.",
            "One of the subsets of this particular gene pool gene produces a protein known as RT or reverse transcrip days, and this is a reverse transcriptase that deliberately makes errors when it, when it transcribes the RNA back into DNA before it makes it into your cell nucleus, and it makes a lot of mistakes.",
            "It's estimated that HIV mutates about a million times more rapidly than we do.",
            "Then our genes do.",
            "So if you've got the immune system, the cellular arm, the immune system attacking HIV at a particular epitope, HIV has a very simple solution, mutate.",
            "Avoid that attack by changing one of the amino acids in that episode."
        ],
        [
            "So if there is strong immune pressure on HIV, we would expect to see a correlation between the mutations we see in HIV infecting somebody and the HLA types of that person.",
            "For example, if the person is a B50, has a B 57 HLA, then we expect to see HIV mutations in or near B 57 epitopes and the reason I say near is that sometimes the flanking regions of these epitopes in the protein.",
            "Can control whether that epitope gets presented on the cell surface so HIV can not only mutate within the episode, but it can mutate nearby the epitope and escape attack from the immune system.",
            "So that's the."
        ],
        [
            "Basic idea of fellow by the name of Simon Mall.",
            "Very smart guy recognized this and tried this about five years ago.",
            "Now published this in science and sure enough he found lots of correlations between persons HLA type and the mutations that you see in HIV.",
            "But there was something a little bit odd about this and that is a lot of the lot of the associations that were found were not in or near known epitopes.",
            "Now it could be that we just didn't know about the right epitopes, but it could be something else, and in fact we now understand that most likely there was just a bug bug in the statistical analysis in this approach."
        ],
        [
            "So let me describe that to you now.",
            "Well, first of all, let me tell you what the approach is that they took.",
            "This is an approximation of what they did actually a simplification of what they did, but it gets the idea across so anyway, what we have here are sequences from eight people were looking at the beginning of what's called the gag protein in HIV.",
            "Here we use letters of the alphabet to code for amino acids.",
            "There's 20 amino acids, so it's convenient to do that.",
            "So here's the first part of gag.",
            "In the first patient.",
            "And let's say this patient has an HLA type that is B 57.",
            "Now we have patient two.",
            "Here's the sequence from that patient.",
            "This patient is not be 57 and so on, and let's just look at this particular position along the HIV protein here and we see some of the patients have R. Some of the patients have K and then we note their HLA's and we build this contingency table.",
            "And here we see a perfect correlation between whether the patient has be 57 or not and whether or not the patient has.",
            "The amino acid R at this position, and if you were to do a simple Fishers exact test, you would come up with a significant P value.",
            "Here P value .3."
        ],
        [
            "OK, but there is.",
            "There's a problem with this approach and that is to 1st approximation ignores the phylogeny.",
            "Of the sequences.",
            "So if we take say 100 HIV sequences and build what's called a phylogenetic tree, I'll say more about this in a moment.",
            "You see lots of structure among the sequences.",
            "You see sequences that are very similar to each other.",
            "Clustering together here in this tree.",
            "And then you see sequences that are very different from each other.",
            "And unless you take this phylogeny into account, you can make mistakes in identifying associations between variables so."
        ],
        [
            "Well, let me show you that.",
            "How that happens, how this ignoring of phylogeny can lead to problems?",
            "Let's go back to our example where we have 8 sequences for those sequences, we're going to look at a particular position along HIV.",
            "Look at the amino acid.",
            "Let's say we see amino acid X4 times and we see amino acid Y and four different individuals, and we see this perfect correlation between having X and having the HLA as before.",
            "OK, but what if?"
        ],
        [
            "The phylogeny of these sequences looks like this.",
            "So basically I'll say more again.",
            "I'll say more about what if I follow genetic tree is in a moment, but basically what this phylogenetic tree is saying is that these four sequences are very similar.",
            "These four sequences are very similar, and these four sequences are not similar to these four sequences.",
            "So now the phylogeny of these sequences offers an explanation for why you see X4 times here and why you see why four times here.",
            "Namely, these four sequences are very similar in these four sequences are very similar, so in doing this counting here in this contingency table, we're really over counting the Association between X and having HLA.",
            "So this analysis overestimates."
        ],
        [
            "Correlation.",
            "In contrast, suppose this were the phylogeny.",
            "So now we've got these four sequences are very similar, but there are similar globally, but at this particular position we see variance in the amino acid.",
            "Sometimes we see X and sometimes we see why and we see X&Y exactly as would be predicted by their age delay.",
            "In this case, the observations are very surprising in light of the phylogeny, and so a simple contingency table like analysis actually.",
            "Underestimates the correlation between these two variables, so you can make mistakes in both directions if you don't take phylogeny into account."
        ],
        [
            "Alright, so we developed a graphical modeling approach that addresses this issue.",
            "Essentially a method for using the phylogeny to look for associations in the data.",
            "We published this just a few months ago in science.",
            "In a nutshell, it goes like this.",
            "First of all, you construct a phylogeny using the sequences that you have using whatever method you like fails, and Steam has a good good approach for doing this, and then you analyze each amino acid at each position.",
            "At each HLA separately do hundreds of thousands of analysis of the following type.",
            "First you build graphical Model 1 which says.",
            "I can explain the amino acid data that I see with the phylogeny alone.",
            "Then you build a second graphical model which says I can explain this data with the phylogeny and by taking into account the HLA of the patient and then you compare these two models and if this second model explains the data much better than this model, you say there is an Association.",
            "That's roughly the idea, so let me go."
        ],
        [
            "To some more details now.",
            "Alright, so we start by building a phylogenetic tree.",
            "Here's a simple phylogenetic tree for five sequences.",
            "The sequences themselves are represented at the leaves of the tree there.",
            "In effect observed nodes, and then these hidden nodes represent ancestors of those sequence ancestor sequences of the observed sequences.",
            "And then we have transitions which are described with the length and the length.",
            "Roughly speaking, corresponds to the evolutionary time that transpired between this ancestor.",
            "And this particular ancestor.",
            "OK, now what we're going to do is take this phylogenetic tree an now at each position along the HIV and each possible amino acid we're going to analyze the appearances of those amino acids across the different patients with this same phylogenetic."
        ],
        [
            "Tree, but we're going to take take the the structure of the phylogenetic tree and interpret it as a Bayes net or a directed acyclic graph.",
            "So now these observe nodes just correspond to binary observations.",
            "Do we see the amino acid or not at this particular position an these hidden nodes correspond to the evolution of this particular amino acid down through the evolutionary tree of the sequences, and we're going to use the length of the transitions.",
            "In this phylogenetic tree to parameterize the conditional probability distributions associated with this with this Bayes net.",
            "To do that, we're going to use what's called a continuous time Markov process.",
            "Basically, we're saying that any at any small transition in time, there's a small probability that the amino acid will mutate from X to not X or from not X to X.",
            "And since our variables are binary, this continuous time Markov process boils down to a very simple thing.",
            "Namely, let's imagine that this node is not X and this and we ask the question, what's the probability that this node is X after its head length time T to evolve well in the continuous time Markov process, that probability increases exponentially to some asymptotes.",
            "The asymptotes is the stationary distribution of X, which we call \u03c0, and the rate at which this probability changes as a function of length T is.",
            "Governed by some exponential rate Lambda.",
            "So with just two parameters we can describe all the conditional probability distributions in this Bayes net.",
            "And given the observations at the leaves and given the structure and given these length length, these evolutionary length we can find say the maximum likelihood values of these parameters very simply with gradient methods or EM.",
            "So that's Model 1 which says we can explain what we're seeing in terms of the amino acid at this particular position.",
            "We can explain that data."
        ],
        [
            "With the phylogeny alone.",
            "The second model says.",
            "Now we need both the phylogeny and we need to know about the patients HLA to explain this data.",
            "So what happens here?",
            "These nodes used to be the observed nodes in Model 1.",
            "Those now become hidden variables and the hidden variables represent what you would expect.",
            "This hidden variable represents what the amino acid in this patient would have been had there been no HLA pressure.",
            "Now the actual observation the amino acid we actually see in the patient is a function of this hidden variable.",
            "And the HLA of the patient.",
            "So we characterize this probability distribution here with some parameters which are tide across all the different patients.",
            "We assume that this HLA pressure is constant across all the patients, so we have a few parameters there and we have these two parameters.",
            "Python, Lambda, given the observations.",
            "Again we can use something like EM to find the maximum likelihood values of these parameters very easily OK."
        ],
        [
            "So those are our two models and again I want to emphasize we're doing this many, many times.",
            "We're doing this analysis for each HLA.",
            "Does the patient have HLA one or not?",
            "Does the patient have HLA two or not so forth and we're doing this analysis for every position along HIV.",
            "There's 3000 of 'em and then we're doing this analysis for every amino acid that we see at every possible position.",
            "So for real data set, we're looking at hundreds of thousands to millions of tests here, so this brings us to the problem of what do you tell the biologist?"
        ],
        [
            "You do these analysis.",
            "Well, you can tell the biologists look.",
            "Here's here's here's one we found where the difference in log likelihoods is very high and they will kind of look at you funny when you tell them about log likelihoods.",
            "You can say, well, I can take this difference in log likelihoods, which is supposed to be chi squared distributed with one degree of freedom.",
            "And I can give you a P value and then of course you have to do corrections for multiple testing.",
            "And if you use some standard method like Bonferroni on 100,000 tests.",
            "You get absolutely nothing, or you can be Bayesian about it, can say, well, let's compute the posterior probability that that Association is present.",
            "And rightly so, they question your analysis, because it turns out the answers you get with this sort of Bayesian analysis can be sensitive to the prior.",
            "So if you can't justify the prior, you."
        ],
        [
            "Not justify the posterior.",
            "I.",
            "So what do biologists really want?",
            "Well, what they really would like is to say, look, give me a list of the most likely associations such that you can promise me that at most 20%, let's say, are spurious.",
            "That is due to chance, or maybe at most 10% or spurious, whatever they want, a list of associations, and they want to know how many of those are likely to be legitimate."
        ],
        [
            "And two folks, Benjamin Hochberg.",
            "Recognize this general need quite awhile back in 1995 and they developed this false discovery rate, which I'll tell you about in a second, at which basically addresses this issue.",
            "So imagine we have some statistical tests, and for simplicity, let's just think about P values.",
            "We have some statistical tests that produces P values and we apply this statistical test to hundreds of thousands of different instances, as in in this problem that we have with HIV.",
            "OK, so we define two quantities S of T, which are the S is the number of associations that we find if we look at all those associations with some P value less than T. And then we define F of T to be the number of those associations that are spurious that are due to chance.",
            "OK, then Benjamin Hochberg define the false discovery rate, which is now function of this threshold T to be the expectation with respect to the true underlying distribution.",
            "The data of the ratio of FT to SFT.",
            "Now we don't know the true underlying distribution of the data, so it's kind of hard to take this expectation, but they came up with a method for estimating this expectation.",
            "Unfortunately, that method was rather complicated."
        ],
        [
            "And it wasn't until about eight years later that story and tips, Ronnie came up with a very simple way to estimate this false discovery rate.",
            "And this is the approach that we use when we apply it to the graphical modeling application that I just described.",
            "So let me go through this briefly.",
            "Here's the false discovery rate as defined by.",
            "Mountain hope work and instead of taking the expectation, the ratio, we're going to take the ratio of the expectations there.",
            "That's often a good approximation under many circumstances, and now to estimate this denominator, we're just going to use the actual number of associations that we found on our data.",
            "This is supposed to be expectation with respect to the true distribution.",
            "Let's just use the actual number that we found an enumerator.",
            "What we want is the expectation of the number of associations that are spurious.",
            "We're going to do is generate a null distribution, a distribution where we know there are no associations.",
            "Apply our method to that data and just count up how many associations we get.",
            "That's an approximation.",
            "But as you'll see, it's it works quite well in practice in many circumstances.",
            "So then you just take the ratio of these two and you've got your false discovery right?",
            "So let's go through this again with a specific example.",
            "Suppose we have we choose a cutoff AP value cutoff of .01, and we imply that P value to hundreds of thousands of tests.",
            "And let's suppose we see 40 associations that come back with a P value less than .01.",
            "Now we generate null data that looks a lot like.",
            "Are real data, but such that it has no real associations in it and we apply our same graphical modeling approach to that.",
            "And let's say after we run several different models we find maybe just eight associations on average that come back with a P value less than this cutoff.",
            "So in this case the false discovery rate is just the ratio 8 to 40, which is 20%.",
            "Now if 20% is too high for the biologists, you can lower the P value cutoff.",
            "Get a get a shorter list with a with a smaller false discovery rate.",
            "The false discovery rates too high.",
            "You can raise the P value cutoff, get a longer list of associations with a larger false discovery rate.",
            "That's all there is to it."
        ],
        [
            "Very very straightforward.",
            "Now how do we generate these null distributions?",
            "Well, in some cases it's difficult, but in our case it's very easy.",
            "We want a distribution that looks just like the real data, but where there's no real associations between HLA and the amino acid that we see in the HIV protein.",
            "So here's our data for HLA.",
            "Here's our data for amino acid.",
            "We just permute the indices of one of these tables, and now we're guaranteed, but we have data that looks very much like the original data, and we're guaranteed there's no true associations.",
            "And in that data will be associations there by accident, but they will be spurious."
        ],
        [
            "OK, so first thing we did is we tried this with synthetic data to make sure it made sense.",
            "So we generated synthetic data that looked a lot like our real data.",
            "I won't go into the details of that.",
            "Then we apply this graphical modeling FDR approach to that data and then we and we did this for various P value cutoff.",
            "So we get different false discovery rates and then we measured the false positives that we saw.",
            "We saw we plotted the false positives that we actually saw versus the estimated false discovery rates that we computed with this story and tips Ronnie."
        ],
        [
            "Method OK, when you do that, you get actually fairly good agreement.",
            "This is the estimated false discovery rate and this is the actual false positive rate that you see in the data.",
            "Again, it's synthetic data, so we know where the real false positives are."
        ],
        [
            "So encouraged by that we went back to the original study that Simon will all published in science.",
            "We used a slightly updated version of his data, applied a sensually the same method that he did to this data, and found roughly 80 significant associations.",
            "This is a data set on roughly 100 patients and again the associations didn't coincide very well with the epitopes that were known at the time.",
            "And now we took our graphical modeling approach with the FDR method, applied it to the same data and we only found eight associations at a false discover rate of .2.",
            "And the biologist went back and did some validation studies on these associations, and sure enough, six out of eight of them were experimentally validated, and that's certainly consistent with this false discovery rate of .2, so.",
            "The good news is that we kind of found the bug with the statistics and fixed it.",
            "But the bad news is my gosh, there's not very many associations here.",
            "Maybe the cellular arm of the immune system doesn't exert a very strong influence on HIV, but of course there's a missing."
        ],
        [
            "Part of the story here, which is when you generate a list of a given false with given false discovery rate.",
            "How many of the true associations are you missing?",
            "What's the false negative rate?",
            "And to do that we just did a sort of a standard power study where you generate synthetic data, apply your approach, and then plot false negative rate as a function of."
        ],
        [
            "The sample size when we do that, you get a curve that looks like this, and sure enough, for sample size is similar to the data set in the science paper analysis we're missing, we find that we're missing over 90% of all the true associations."
        ],
        [
            "Now I got lucky.",
            "I did a mini sabbatical at mass general last summer.",
            "And just as I arrived, a postdoc arrived and she had the perfect data set.",
            "She had about 600 patients, patients where she knew their HLA types and she knew their HIV sequences and so we applied this approach to that larger data set and sure enough, we found lots and lots of associations.",
            "An at this sample size, we estimate that we're still missing about half the Association, so you should really multiply these numbers roughly by two so you can see there's a lot of associations here.",
            "For example, in the protein.",
            "Now these are different proteins in HIV, protease, RTF for the protein NEF, there is well over.",
            "Others about.",
            "270 two 180 or so associations found enough and there's only 206 positions in the protein, so of course there's.",
            "These associations are also HLA dependent, so there's still.",
            "I mean, the bottom line is there's a lot of associations here, and this has started to convince people that there really is hope for a cellular vaccine for HIV, because the obviously the cellular Army immune system exerts very strong pressure on HIV.",
            "I should also say that.",
            "The biologist went back and did some validation studies on these associations, and again they found that about 80% of these made sense biologically and again the false discovery rate that we used to do this was .2.",
            "So those numbers are consistent."
        ],
        [
            "Alright.",
            "Now, since we've developed this method, biologists have started using it and finding out all sorts of interesting things about HIV.",
            "I'd like to tell you about one thing that they've learned.",
            "I should say they used other approaches in addition to our approach to learn this, but it's a very exciting observation, and it has profound implications for HIV vaccine design.",
            "And that is, we've discovered that HIV has both good epitopes and bad epitopes.",
            "Now a good epitope.",
            "Is sort of the way I described it earlier.",
            "You've got the immune system attacking HIV.",
            "HIV has to mutate away to avoid that attack, and in so doing it either kills itself or its weakened.",
            "That's a good epitope.",
            "A bad epitope is a situation where the immune system attacks HIV, HIV mutates, and it survives quite happily, but at the expense of the immune system.",
            "Immune system is now wasted its energy attacking HIV in this position to no good.",
            "So it turns out HIV is throwing out.",
            "We thank all these decoys, lots and lots of bad epitope decoys.",
            "Wasting the time of the immune system so that in the hopes that it won't.",
            "Add immune system will not have enough energy left to attack the good epitopes.",
            "And so with this insight, it sort of becomes clear how you might want to design A vaccine.",
            "What you want to do is identify the good epitopes, put those good epitopes in a vaccine that would then train your immune system to recognize those epitopes ahead of you being infected.",
            "And by all means avoiding the bad epitopes in the vaccine.",
            "You do not want to put these bad epitopes in the vaccine, and it turns out Ascentia Lee all the vaccine designs that we've seen so far have not paid attention to this distinction.",
            "And it's very likely that there's bad epitopes in these vaccine designs, which may be an explanation for why they haven't worked.",
            "So this is all very encouraging, but it brings us to the second application."
        ],
        [
            "Now I'm going to talk about which is where are these epitopes?",
            "Now let me remind you that an epitope is really a relation.",
            "It has to do with whether a peptide a particular, let's say 9 amino acid long peptide binds inside of a particular HLA molecule.",
            "So we've got to find both the peptide in the HLA well.",
            "Finding the peptides is fairly easy because epitopes are going to exist either in regions where we found our HLA HIV associations that I just showed you, or in regions where HIV doesn't mutate at all.",
            "So those are the likely candidates for the peptides.",
            "Then we have to find the HLA alleles that go with those peptides to make the epitopes and this is going to be a little tricky 'cause there's hundreds of different types of HLA molecules that's rather expensive to do this in the lab, and so the subject of this work that I'm going to talk about is given a peptide.",
            "How do you figure out which hlas make that peptide and epitope?",
            "And again we need to know which HLA's do this because we want to build a vaccine for a population of people where there's a distribution of HLA types and we want to make sure that this vaccine.",
            "Can cover a lot of these."
        ],
        [
            "HLA types in the population.",
            "So here's how we do it.",
            "This is work with Christian Brander and Nicole from at mass general.",
            "We take a peptide.",
            "We manufacture peptide that we think might be an epitope and we mix it with the blood of several different patients, maybe 100 different patients.",
            "Then if there is a reaction in this test tube, it's called an elispot reaction.",
            "If we see this reaction, it means that very likely one of the six HLA types of this patient is responsible for this being an epitope.",
            "This peptide being an epitope.",
            "Now we don't know which of the six."
        ],
        [
            "But since we have observations across many patients, we can tease out what the HLA types are.",
            "For example, if these two patients react and none of the other patients do well, we see that these two patients have be 58 in common, but the rest of the patients don't, so it's very likely that be 58 in combination with this peptide."
        ],
        [
            "Is an epitope.",
            "Of course, that's oversimplification.",
            "There are complications or false negatives.",
            "There's false positives.",
            "Sometimes you can have more than one HLA being responsible for a particular peptide being an epitope.",
            "So how do you get partial credit?",
            "This just shows how messy it can get.",
            "This row of patients here.",
            "Each column corresponds to a patient.",
            "Patients reacted.",
            "To a particular peptide, these patients didn't react to a particular peptide, and the correct solution, the HLA's, that are responsible for this peptide being epitope, are 823 and read a two and blue and C2 in green, so you can see there's false positives here.",
            "We've got a patient that has none of these hlas Bhutan.",
            "They they do react and here we have a patient that has some of these HLA levels that are responsible for this peptide being epitope, but they don't react.",
            "OK, so."
        ],
        [
            "It's a messy problem, but in this community that doesn't.",
            "That doesn't stop us in this case.",
            "Simple graphical model addresses the uncertainty.",
            "Here we can use a bipartite directed acyclic graph where the upper level corresponds to whether the patient has the HLA or not.",
            "The lower level represents whether the patient reacts to a particular peptide or not.",
            "This is reacting to peptide one reacting to peptide two and so forth, and then to deal with the multiple credit problem we just use a noisy or distribution here.",
            "So if a particular peptide.",
            "Can react with both HLA one and HLA three.",
            "We increase the probability that it's going to react according to a noisy or model which when you talk to the biologists they say that makes sense.",
            "Now what's an epitope here?",
            "Well, what we're going to do is take the data and do sort of standard Bayes net learning, Bayes net structure, learning an.",
            "Whenever we find an arc here, well that corresponds.",
            "There being an epitope in arc means that having this HLA influences the probability that you're going to react and so basically.",
            "An arc corresponds to there being an epitope."
        ],
        [
            "The presence of an art corresponds to there being an epitope.",
            "So now let's go back to this problem with the biologists.",
            "Want I tried showing him the Bayes net you get from structure learning, which is the most likely network structure and they kind of look at you funny and they say no, we don't trust that based on that, how many of these arcs are legit legitimate?",
            "So we come back to this false discovery rate problem.",
            "We want to list of epitopes, IE list of arcs in the graph and we want to know how many of those arcs are due to chance."
        ],
        [
            "Well, it turns out that this very simple method.",
            "That story and tips Ronnie developed for estimating the false discovery rate can be applied very easily to this problem of Bayes net or directed acyclic graph model learning, and this is some work that I've done with Jennifer Liz Garton.",
            "I'm just going to give you the bare Bones story here.",
            "We're going to present this in detail at UI in just a few weeks, so here's how it goes.",
            "When we were given some data.",
            "And we have some structure learning algorithm A.",
            "Any algorithm you want any algorithm for learning structure that you like and what we want to output is obviously the Bayes net and also an estimate of how many arcs.",
            "Net based net are Spurs.",
            "How many of those arcs are due to chance?",
            "Now to make things easy we're going to do all the simple assumptions.",
            "We're going to assume that the node parameters are independent and then we have complete data so we can learn the parents of each node separately and we're going to assume the node ordering is.",
            "The note ordering is known.",
            "That's true for the problem we have that I just showed you and also makes it very easy to decide whether an arc is spurious or not.",
            "So let's stick with those.",
            "The simple case and the way we compute the false discovery rate is just analogous, very analogous to what we did in the first problem.",
            "First of all, we take our algorithm and apply it to the real data, and we just count how many arcs we get.",
            "Then we take our real data and generate null distributions from that data distributions where we know there are no real.",
            "Associations there and then we feed that data to our model selection algorithm and see how many arcs it hallucinates.",
            "OK, so we got the expected number of arcs under the null and we get that by averaging over a bunch of nulls to get rid of noise in the estimate and we just divide that by the actual number of arcs that we see on the real data.",
            "That's our false discovery rate.",
            "So the 1st."
        ],
        [
            "Question is, how well does that work?",
            "Well, here's an example on synthetic data.",
            "We generated some data that looked a lot like the original data.",
            "And we plot here estimated false discovery rate as a function of the actual fraction of false positives in the data, and you can see that at least 4 lower false discovery rates 10% twenty percent 30% you get quite a good agreement, and this is the range where biologists are interested anyway.",
            "Relatively small false discovery rates, so that's good news.",
            "You do see the curve peel away here, though we think we understand why that occurs, and we think we have a solution to that.",
            "But I won't go through the details there.",
            "If you're interested, come to UA or obviously come."
        ],
        [
            "And talk to me after the talk.",
            "So now we've got this approach, which looks pretty good on synthetic data.",
            "Let's go back to the real data.",
            "Going into this there 169 HIV epitopes known.",
            "And we took some real data, about 100 patients and measured about 100 peptides and a false discovery rate of .3.",
            "We found 118 additional additional epitopes now it's very difficult to verify these epitopes, so so far they've only verified seven out of seven, which is consistent with this false discovery rate.",
            "But they have a long way to go in verifying these.",
            "But anyway, one of the things we learned, assuming assuming this list is correct, one of the things that we've learned that's interesting for the biologist is.",
            "Going into this study, it was thought that if you have a single epitope, maybe 1, maybe two HLA's, or if you had a single peptide.",
            "Excuse me, maybe one or two hlas would make that peptide an epitope.",
            "But with this study, it looks like more like it looks more like 3456.",
            "Hlas will all make the same peptide and epitope and that again is very good news for vaccine design because you want to put.",
            "In a vaccine epitopes that cover a broad range of HLA types, and here we're learning that there often can be more than one.",
            "In fact, up to six HLA's that can present a particular peptide as being an app."
        ],
        [
            "Tub so that's about it.",
            "And graphical models are helping with the design of HIV vaccine using graphical models, we've learned that HIV is highly vulnerable to the cellular arm of the immune system.",
            "We're finding and we're using graphical models defined epitopes to include in the vaccine, and Conversely, in the process of developing these graphical model approaches for the biologists, I've learned something very important that they when you give them a graphical model, they want to know how many of those arcs are due to chance and using the false discovery rate.",
            "We can give him an estimate of that quantity, and finally we've the biologists are starting to use these tools.",
            "We put them online.",
            "We also put the source code online so people can look at these methods and hopefully enhance them.",
            "So if you're interested, the tools are available at Microsoft.",
            "Com dance."
        ],
        [
            "Slash science and finally, I want to thank.",
            "Several folks, Betty corporate Amway but Acharia at Los Alamos National labs.",
            "We had some great discussions about how use phylogeny to correct for finding these associations in the data and also of course the biologist themselves.",
            "They're very clever.",
            "They come up with these brilliant hypothesis to test, and of course for the data that they provided.",
            "Thank you very much.",
            "Thanks for questions.",
            "Yes.",
            "Do you wanna pass a Mike?",
            "The Association between.",
            "How does it?",
            "How does it help the vaccine design design such that it's?",
            "I mean it's personalized to specific individuals because, well, it when you find first of all, if you find an Association, there's gotta be an epitope there somewhere.",
            "So then you can use the second application I showed you.",
            "Or other more expensive methods to find that actual epitope.",
            "Now you've got a peptide that you conclude in.",
            "You can include in the vaccine that will make at least the people with that HLA type will help them fight the virus if they get infected.",
            "But as I just showed you, that one peptide may also be appropriate for three or four other types of HLA, so you get a little bit broader coverage.",
            "So the trick is to find some epitopes that tend to have broad coverage across the HLA's good epitopes as opposed to the bad ones and get them into the.",
            "Vaccine.",
            "So it's not a vaccine is not going to consist of 1 epitope, it's going to consist of numerous epitopes.",
            "Hopefully a small number.",
            "The smaller the vaccine, the easier it is to get into your body.",
            "There's less chances for bad reactions and so forth, so there's going to be this tradeoff between how many people we can cover, what fraction of the population we can cover, and how, how long this vaccine is going to be.",
            "I should say there's as if Salon HLA types, so it's not like.",
            "There's 1 /, 100 of each type of a baby, and see some types are much more common than the other, so using the Zips law we can get pretty far down the tail covering some of covering the top 20% of hlas let's.",
            "So I I thought it was wonderful that you had both for the false discovery rate in the 1st.",
            "First both false memory, right analog power for that way on the second problem is that you do that, yeah?",
            "We we I can't remember now I know is over 50%.",
            "But yeah, there's a lot of epitopes out there left to be discovered.",
            "We need some more data.",
            "Shoulders.",
            "Overestimates correlation.",
            "They can either overestimate or underestimate, depending on what the phylogeny phylogenetic structure.",
            "In this case, the overestimations.",
            "We did find some false negatives though too.",
            "So in the original data they missed some of the associations that we picked up.",
            "Coalition.",
            "Approximately.",
            "Actually.",
            "Yeah.",
            "This is very quickly.",
            "Oh well it can.",
            "It have to do.",
            "It.",
            "Can have to do with geography.",
            "For example different parts of Africa.",
            "Let's say have different distributions of HLA type and different parts of Africa also have different HIV vaccines.",
            "Just because the spread tends to be local so that actually isn't the explanation for all of the Association or for all of the overestimation.",
            "But it is an explanation for a good chunk of the overestimation.",
            "There's one illegal, in particular at C 1701.",
            "Which occurs in certain regions which has this certain set of HIV sequences and that was responsible for vast large number of these false or spurious associations.",
            "So in the second part of the talk, when you when you discuss epitopes, I believe you mean would have it also only what we want.",
            "We want to find all the epitopes and then we have to.",
            "There's a separate procedure you to to decide whether it's a good epitope.",
            "Could it be possible that a certain epitope is good modular, certain natural rights and back orders from others?",
            "Because that could be quite noticed.",
            "It's quite possible.",
            "In that case you just don't put it in the vaccine.",
            "So you have to give up some of the benefits of the epitope for some part of the population.",
            "So are there any lessons here?",
            "Biological applications.",
            "Well, yeah, I've been talking to voices Goldsmith recently and he's doing applications from Microsoft involving systems maintenance, and he's come across exactly the same problem, which is the people he's worked with when you show them a Bayes net, they don't trust it.",
            "They want to know how many of the arcs are just hallucinated, and he's now trying this approach in that environment, and I think generally this is something that's bothered me for years.",
            "Anyway, I.",
            "People have throughout the years when I've showed them analysis from time to time, they've raised the question, you know, well, how can you?",
            "How confident can I be in this structure?",
            "Give me some measures that I can I can wrap my head around and I've never really been able to do that satisfactorily.",
            "To know, I think so I think it's going to have lots of applications.",
            "Answer my question.",
            "I did the biologists wrong grumbling at here, no?",
            "No.",
            "Also, the great give additional new information, so it definitely gives additional new information.",
            "They were right on the money, you know.",
            "Shame.",
            "Shame on me for not having dealt with this before talking with them, but in working with them it just became absolutely clear that they would not trust anything I said and less.",
            "I provided them with some measures like this.",
            "I think so.",
            "You used to be a Bayesian.",
            "What happened?",
            "Ask like I still use whatever works is is what I am so you know I'm using Bayesian techniques to build the structure in the 1st place.",
            "But yes I'm using frequentist methods to decide how many of those are extra spurious it works.",
            "Thanks for noticing.",
            "So in the first application, your model that HLA executive pressure on the observed variables only doesn't age legs or pressure.",
            "Absolutely absolutely.",
            "Maybe I should let me get to that slide.",
            "That's a very good question.",
            "Sex."
        ],
        [
            "Yes, or is it here?",
            "OK, so isn't there HLA pressure going on here too?",
            "Absolutely, but this transition supposedly represents hundreds of transmissions from one patient to the next.",
            "An one patient is going to have the HLA, the next patient is not going to have the HLA, so roughly on average you're going to characterize this transition with some stationary distribution and some exponential rate of mutation.",
            "Which is going to vary depending on how much HLA influences there.",
            "So because we're fitting this model including the pion Lambda parameters, given the data that we see, we think at least to a first approximation that we're taking that into account in a reasonable way.",
            "Now, if I knew if I knew the pedigree of of the HIV infections this person gave it to this person, which gave it to that person, then I could build a much better Bayes net which represented the HLA influences all along the way.",
            "Can I ask a question just following up?",
            "Is there in one 5 number for each locus absolutely for every HLA, for every amino acid for every position?",
            "Treating no no.",
            "We still have time for one or two more.",
            "Did you really provided an unordered set of associations to biologists or you know they like they like to know which ones are most likely and we just sort them by P value?",
            "It's at the top after after you get some experimental.",
            "Oh, the ones near the top.",
            "I mean you can build false to list with different false discovery rates and the ones at the top survive.",
            "Even small false discovery rates.",
            "And sure enough, those are the ones that hire you up on the list.",
            "The more likely you are they were validated by the biologists, definitely.",
            "One last question.",
            "What is the best value?",
            "The smallest P value.",
            "OG 10 -- 17 or something like that, yeah?",
            "OK, well thank you very much.",
            "Inside"
        ]
    ],
    "summarization": {
        "clip_0": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Machine learning an applied statistics group at Microsoft Research.",
                    "label": 0
                },
                {
                    "sent": "I David is one of my heroes in machine learning, I think exemplifies.",
                    "label": 0
                },
                {
                    "sent": "The kind of excellent person that is attracted to work in this area by bringing together both really deep understanding of the theoretical and mathematical foundations of the field with a tremendous commitment to doing applied research.",
                    "label": 0
                },
                {
                    "sent": "And this goes back a long way actually before he was doing anything related to learning at all, he got an MD and PhD at Stanford because he was committed to trying to do artificial intelligence and decision science in.",
                    "label": 0
                },
                {
                    "sent": "In medicine, but then you know the attraction of actually learning from data grip him.",
                    "label": 0
                },
                {
                    "sent": "He's worked on all kinds of different things at Microsoft Research, data mining, product, large scale DM lots, and lots of variations on decision theory.",
                    "label": 0
                },
                {
                    "sent": "Of course, he's worked on diagnosis, so there are several components in at least this box you know that have to have that bear his fingerprints.",
                    "label": 0
                },
                {
                    "sent": "So without further ado, let me introduce David Heckerman who's talking about yet another.",
                    "label": 0
                },
                {
                    "sent": "Make progress with HIV.",
                    "label": 0
                },
                {
                    "sent": "Next time, thank you.",
                    "label": 0
                },
                {
                    "sent": "Thank you, it's a pleasure to be here.",
                    "label": 0
                },
                {
                    "sent": "I would like to thank the organizers for inviting me and I'd like to thank you all for hanging in there to the end.",
                    "label": 0
                },
                {
                    "sent": "This is for the camera.",
                    "label": 0
                },
                {
                    "sent": "Is this an hello?",
                    "label": 0
                },
                {
                    "sent": "Oh, OK, I'll do the.",
                    "label": 0
                },
                {
                    "sent": "I'll do the nightclub routine here is this working.",
                    "label": 0
                },
                {
                    "sent": "OK, very good, alright well.",
                    "label": 0
                },
                {
                    "sent": "How about three or four years ago I came onto this problem of HIV vaccine design and it had some interesting success and it brought me into discussions with lots of HIV researchers, and I began to listen to them understand their problems and found a couple of really interesting applications of graphical models that at least I thought would help them.",
                    "label": 0
                },
                {
                    "sent": "And it turns out that it has.",
                    "label": 0
                },
                {
                    "sent": "So today I'd like to share those applications with you and also in the process of developing these graphical model applications for HIV vaccine design.",
                    "label": 0
                },
                {
                    "sent": "I learned from the biologist I learned that there was something that we were doing with graphical model learning that wasn't satisfying them.",
                    "label": 0
                },
                {
                    "sent": "There was a real weakness in graphical model learning, so I identified that and came up with a solution that I'll share with you as well.",
                    "label": 0
                },
                {
                    "sent": "And I should say this is not my own work, this is.",
                    "label": 0
                },
                {
                    "sent": "Only my work, this is joint work with Charles, Jonathan Carlson, Jennifer Liz, Garton Ann Karl Katie.",
                    "label": 0
                }
            ]
        },
        "clip_1": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "All at Microsoft Research.",
                    "label": 0
                },
                {
                    "sent": "So I don't think I need to emphasize very much the importance or the need for an HIV vaccine.",
                    "label": 0
                },
                {
                    "sent": "HIV and the disease it causes, namely AIDS, is one of the deadliest pandemics in recorded history.",
                    "label": 0
                },
                {
                    "sent": "About 10,000 people die per day of AIDS.",
                    "label": 0
                },
                {
                    "sent": "Treatments are great.",
                    "label": 0
                },
                {
                    "sent": "Now they've come up with some great treatments, but they're very expensive.",
                    "label": 0
                },
                {
                    "sent": "And if you miss a few doses, the virus can come back and even a stronger form and kill you very rapidly.",
                    "label": 0
                },
                {
                    "sent": "So treatments are great if you live in Europe or the United States.",
                    "label": 0
                },
                {
                    "sent": "But they're not good if you live in a developing country and there a vaccine.",
                    "label": 0
                }
            ]
        },
        "clip_2": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "It is still the greatest hope.",
                    "label": 0
                },
                {
                    "sent": "So what I thought I'd do is first just give you some background in HIV and our immune system which fights HIV.",
                    "label": 0
                },
                {
                    "sent": "Then go over these two graphical modeling applications.",
                    "label": 0
                },
                {
                    "sent": "Then describe this weakness in graphical model learning that it was alluding to, and then show you a solution we've come up with.",
                    "label": 0
                },
                {
                    "sent": "It's based on what's known as the.",
                    "label": 0
                }
            ]
        },
        "clip_3": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "False discovery rate.",
                    "label": 0
                },
                {
                    "sent": "So HIV is a retrovirus and it uses your own cells to make more of itself.",
                    "label": 0
                },
                {
                    "sent": "So basically HIV is a BI lipid particle with a BI lipid membrane with some proteins sticking out of it, an RNA payload.",
                    "label": 0
                },
                {
                    "sent": "These proteins help the HIV particle fuse with your own cells membrane when the Fusion happens, the RNA gets out, gets reverse transcribed to DNA, which then makes it into your nucleus.",
                    "label": 0
                },
                {
                    "sent": "And then your nucleus produces more RNA, which then produces more HIV proteins.",
                    "label": 0
                },
                {
                    "sent": "These proteins and the RNA assemble and butt off from the cell wall, forming many new particles which go off and infect.",
                    "label": 0
                }
            ]
        },
        "clip_4": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Other self now there's two ways our immune system fights HIV an in fact, retroviruses in general, there's two arms of our adaptive immune system.",
                    "label": 0
                },
                {
                    "sent": "The humor alarm, which manufacturers antibodies, and these antibodies recognize an neutralize these particles as they are floating freely in your body.",
                    "label": 0
                },
                {
                    "sent": "And then there's the cellular arm of the immune system, which uses what are called killer T cells.",
                    "label": 0
                },
                {
                    "sent": "This is basically a subset of your white blood cells.",
                    "label": 0
                },
                {
                    "sent": "Which identify and destroy your own cells that have been infected, thus producing the virus from.",
                    "label": 0
                }
            ]
        },
        "clip_5": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Reading further.",
                    "label": 0
                },
                {
                    "sent": "Now, HIV has been around for about 20 years and people have been trying for these 20 years to build a humoral arm vaccine, a vaccine based on antibodies, and so far they have not met.",
                    "label": 0
                },
                {
                    "sent": "Met with success.",
                    "label": 0
                },
                {
                    "sent": "There's over 170 trials, I think that have gone on.",
                    "label": 0
                },
                {
                    "sent": "None of them have produced or show that a vaccine to be a viable candidate yet.",
                    "label": 0
                },
                {
                    "sent": "So more recently, people have been looking at the cellular arm of the immune system for vaccine design, and there there is a fundamental question.",
                    "label": 0
                },
                {
                    "sent": "Is the cellular arm of our immune system strong enough to fight HIV and this question?",
                    "label": 0
                },
                {
                    "sent": "The answer of this question has been quite controversial.",
                    "label": 0
                },
                {
                    "sent": "As you'll see we use graphical models to help.",
                    "label": 0
                }
            ]
        },
        "clip_6": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Answer this question so we're going to focus on the cellular arm of the immune system for this part of the talk, so let me give you a few details about this arm of the immune system.",
                    "label": 0
                },
                {
                    "sent": "So as proteins are being manufactured in your cells, some subset of them get chopped up into little bits.",
                    "label": 0
                },
                {
                    "sent": "So proteins or strings of amino acids.",
                    "label": 0
                },
                {
                    "sent": "These bits tend to be anywhere from 8 to 11 amino acid.",
                    "label": 0
                },
                {
                    "sent": "Long strings of amino acids, and they're called epitopes.",
                    "label": 0
                },
                {
                    "sent": "And these epitopes bind, which with water called HLA molecules human Lucas.",
                    "label": 0
                }
            ]
        },
        "clip_7": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Light energy and molecules and these HLA molecules transport the epitope to the cell surface.",
                    "label": 0
                },
                {
                    "sent": "So they're right there outside the cell, viz.",
                    "label": 0
                }
            ]
        },
        "clip_8": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Two other cells and then a killer T cell can come along.",
                    "label": 0
                },
                {
                    "sent": "That's been pre trained to recognize this combination and say ah ha, you're a foreign epitope.",
                    "label": 0
                }
            ]
        },
        "clip_9": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "You don't belong there.",
                    "label": 0
                },
                {
                    "sent": "I'm going to kill the cell that you're exposed on an in so doing new virus particles can't be manufactured by this cell, any law.",
                    "label": 0
                }
            ]
        },
        "clip_10": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Eager.",
                    "label": 0
                },
                {
                    "sent": "OK, so the question here the fundamental question if you're going to design A vaccine for HIV based on the cellular immune system, is is the cellular arm of the immune system effective on HIV is this?",
                    "label": 0
                }
            ]
        },
        "clip_11": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And then I just showed you effective on HIV.",
                    "label": 0
                },
                {
                    "sent": "So to understand how we might answer that question, I need to tell you three things.",
                    "label": 0
                },
                {
                    "sent": "The first thing is these HLA molecules.",
                    "label": 0
                },
                {
                    "sent": "They are very diverse.",
                    "label": 0
                },
                {
                    "sent": "There's three genes that code for HLA molecules in your body.",
                    "label": 0
                },
                {
                    "sent": "They're very creatively named the aging.",
                    "label": 0
                },
                {
                    "sent": "The BG Nancy Jean and they're very diverse.",
                    "label": 0
                },
                {
                    "sent": "There's hundreds of different types of AA, hundreds of different types of bees, hundreds of different types of CS which have two chromosomes.",
                    "label": 0
                },
                {
                    "sent": "We get 2 copies of the gene, so we have two as two bees and two seas.",
                    "label": 0
                },
                {
                    "sent": "So the chances that any two of us have the same HLA 6 HLA types is very small.",
                    "label": 0
                },
                {
                    "sent": "It's like one in 10,000,000.",
                    "label": 0
                },
                {
                    "sent": "The second thing you need to know is that this epitope binding in the HLA molecule is very specific.",
                    "label": 0
                },
                {
                    "sent": "So what is an epitope for a particular HLA molecule will very likely not be an epitope for another HLA Mal.",
                    "label": 0
                }
            ]
        },
        "clip_12": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Kill.",
                    "label": 0
                },
                {
                    "sent": "The third thing you need to know is that HIV mutates very rapidly.",
                    "label": 0
                },
                {
                    "sent": "This is the entire map of HIV.",
                    "label": 0
                },
                {
                    "sent": "It's amazingly small, it's only HIV is only 3000 amino acids long, and these are the proteins that get coded.",
                    "label": 0
                },
                {
                    "sent": "One of the subsets of this particular gene pool gene produces a protein known as RT or reverse transcrip days, and this is a reverse transcriptase that deliberately makes errors when it, when it transcribes the RNA back into DNA before it makes it into your cell nucleus, and it makes a lot of mistakes.",
                    "label": 0
                },
                {
                    "sent": "It's estimated that HIV mutates about a million times more rapidly than we do.",
                    "label": 0
                },
                {
                    "sent": "Then our genes do.",
                    "label": 0
                },
                {
                    "sent": "So if you've got the immune system, the cellular arm, the immune system attacking HIV at a particular epitope, HIV has a very simple solution, mutate.",
                    "label": 0
                },
                {
                    "sent": "Avoid that attack by changing one of the amino acids in that episode.",
                    "label": 0
                }
            ]
        },
        "clip_13": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So if there is strong immune pressure on HIV, we would expect to see a correlation between the mutations we see in HIV infecting somebody and the HLA types of that person.",
                    "label": 0
                },
                {
                    "sent": "For example, if the person is a B50, has a B 57 HLA, then we expect to see HIV mutations in or near B 57 epitopes and the reason I say near is that sometimes the flanking regions of these epitopes in the protein.",
                    "label": 0
                },
                {
                    "sent": "Can control whether that epitope gets presented on the cell surface so HIV can not only mutate within the episode, but it can mutate nearby the epitope and escape attack from the immune system.",
                    "label": 0
                },
                {
                    "sent": "So that's the.",
                    "label": 0
                }
            ]
        },
        "clip_14": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Basic idea of fellow by the name of Simon Mall.",
                    "label": 0
                },
                {
                    "sent": "Very smart guy recognized this and tried this about five years ago.",
                    "label": 0
                },
                {
                    "sent": "Now published this in science and sure enough he found lots of correlations between persons HLA type and the mutations that you see in HIV.",
                    "label": 0
                },
                {
                    "sent": "But there was something a little bit odd about this and that is a lot of the lot of the associations that were found were not in or near known epitopes.",
                    "label": 0
                },
                {
                    "sent": "Now it could be that we just didn't know about the right epitopes, but it could be something else, and in fact we now understand that most likely there was just a bug bug in the statistical analysis in this approach.",
                    "label": 0
                }
            ]
        },
        "clip_15": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So let me describe that to you now.",
                    "label": 0
                },
                {
                    "sent": "Well, first of all, let me tell you what the approach is that they took.",
                    "label": 0
                },
                {
                    "sent": "This is an approximation of what they did actually a simplification of what they did, but it gets the idea across so anyway, what we have here are sequences from eight people were looking at the beginning of what's called the gag protein in HIV.",
                    "label": 0
                },
                {
                    "sent": "Here we use letters of the alphabet to code for amino acids.",
                    "label": 0
                },
                {
                    "sent": "There's 20 amino acids, so it's convenient to do that.",
                    "label": 0
                },
                {
                    "sent": "So here's the first part of gag.",
                    "label": 0
                },
                {
                    "sent": "In the first patient.",
                    "label": 0
                },
                {
                    "sent": "And let's say this patient has an HLA type that is B 57.",
                    "label": 0
                },
                {
                    "sent": "Now we have patient two.",
                    "label": 0
                },
                {
                    "sent": "Here's the sequence from that patient.",
                    "label": 0
                },
                {
                    "sent": "This patient is not be 57 and so on, and let's just look at this particular position along the HIV protein here and we see some of the patients have R. Some of the patients have K and then we note their HLA's and we build this contingency table.",
                    "label": 0
                },
                {
                    "sent": "And here we see a perfect correlation between whether the patient has be 57 or not and whether or not the patient has.",
                    "label": 0
                },
                {
                    "sent": "The amino acid R at this position, and if you were to do a simple Fishers exact test, you would come up with a significant P value.",
                    "label": 0
                },
                {
                    "sent": "Here P value .3.",
                    "label": 0
                }
            ]
        },
        "clip_16": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "OK, but there is.",
                    "label": 0
                },
                {
                    "sent": "There's a problem with this approach and that is to 1st approximation ignores the phylogeny.",
                    "label": 0
                },
                {
                    "sent": "Of the sequences.",
                    "label": 0
                },
                {
                    "sent": "So if we take say 100 HIV sequences and build what's called a phylogenetic tree, I'll say more about this in a moment.",
                    "label": 0
                },
                {
                    "sent": "You see lots of structure among the sequences.",
                    "label": 0
                },
                {
                    "sent": "You see sequences that are very similar to each other.",
                    "label": 0
                },
                {
                    "sent": "Clustering together here in this tree.",
                    "label": 0
                },
                {
                    "sent": "And then you see sequences that are very different from each other.",
                    "label": 0
                },
                {
                    "sent": "And unless you take this phylogeny into account, you can make mistakes in identifying associations between variables so.",
                    "label": 0
                }
            ]
        },
        "clip_17": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Well, let me show you that.",
                    "label": 0
                },
                {
                    "sent": "How that happens, how this ignoring of phylogeny can lead to problems?",
                    "label": 0
                },
                {
                    "sent": "Let's go back to our example where we have 8 sequences for those sequences, we're going to look at a particular position along HIV.",
                    "label": 0
                },
                {
                    "sent": "Look at the amino acid.",
                    "label": 0
                },
                {
                    "sent": "Let's say we see amino acid X4 times and we see amino acid Y and four different individuals, and we see this perfect correlation between having X and having the HLA as before.",
                    "label": 0
                },
                {
                    "sent": "OK, but what if?",
                    "label": 0
                }
            ]
        },
        "clip_18": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "The phylogeny of these sequences looks like this.",
                    "label": 0
                },
                {
                    "sent": "So basically I'll say more again.",
                    "label": 0
                },
                {
                    "sent": "I'll say more about what if I follow genetic tree is in a moment, but basically what this phylogenetic tree is saying is that these four sequences are very similar.",
                    "label": 0
                },
                {
                    "sent": "These four sequences are very similar, and these four sequences are not similar to these four sequences.",
                    "label": 0
                },
                {
                    "sent": "So now the phylogeny of these sequences offers an explanation for why you see X4 times here and why you see why four times here.",
                    "label": 0
                },
                {
                    "sent": "Namely, these four sequences are very similar in these four sequences are very similar, so in doing this counting here in this contingency table, we're really over counting the Association between X and having HLA.",
                    "label": 0
                },
                {
                    "sent": "So this analysis overestimates.",
                    "label": 0
                }
            ]
        },
        "clip_19": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Correlation.",
                    "label": 0
                },
                {
                    "sent": "In contrast, suppose this were the phylogeny.",
                    "label": 0
                },
                {
                    "sent": "So now we've got these four sequences are very similar, but there are similar globally, but at this particular position we see variance in the amino acid.",
                    "label": 0
                },
                {
                    "sent": "Sometimes we see X and sometimes we see why and we see X&Y exactly as would be predicted by their age delay.",
                    "label": 0
                },
                {
                    "sent": "In this case, the observations are very surprising in light of the phylogeny, and so a simple contingency table like analysis actually.",
                    "label": 0
                },
                {
                    "sent": "Underestimates the correlation between these two variables, so you can make mistakes in both directions if you don't take phylogeny into account.",
                    "label": 0
                }
            ]
        },
        "clip_20": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Alright, so we developed a graphical modeling approach that addresses this issue.",
                    "label": 0
                },
                {
                    "sent": "Essentially a method for using the phylogeny to look for associations in the data.",
                    "label": 0
                },
                {
                    "sent": "We published this just a few months ago in science.",
                    "label": 0
                },
                {
                    "sent": "In a nutshell, it goes like this.",
                    "label": 0
                },
                {
                    "sent": "First of all, you construct a phylogeny using the sequences that you have using whatever method you like fails, and Steam has a good good approach for doing this, and then you analyze each amino acid at each position.",
                    "label": 0
                },
                {
                    "sent": "At each HLA separately do hundreds of thousands of analysis of the following type.",
                    "label": 0
                },
                {
                    "sent": "First you build graphical Model 1 which says.",
                    "label": 0
                },
                {
                    "sent": "I can explain the amino acid data that I see with the phylogeny alone.",
                    "label": 0
                },
                {
                    "sent": "Then you build a second graphical model which says I can explain this data with the phylogeny and by taking into account the HLA of the patient and then you compare these two models and if this second model explains the data much better than this model, you say there is an Association.",
                    "label": 0
                },
                {
                    "sent": "That's roughly the idea, so let me go.",
                    "label": 0
                }
            ]
        },
        "clip_21": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "To some more details now.",
                    "label": 0
                },
                {
                    "sent": "Alright, so we start by building a phylogenetic tree.",
                    "label": 0
                },
                {
                    "sent": "Here's a simple phylogenetic tree for five sequences.",
                    "label": 0
                },
                {
                    "sent": "The sequences themselves are represented at the leaves of the tree there.",
                    "label": 0
                },
                {
                    "sent": "In effect observed nodes, and then these hidden nodes represent ancestors of those sequence ancestor sequences of the observed sequences.",
                    "label": 0
                },
                {
                    "sent": "And then we have transitions which are described with the length and the length.",
                    "label": 0
                },
                {
                    "sent": "Roughly speaking, corresponds to the evolutionary time that transpired between this ancestor.",
                    "label": 0
                },
                {
                    "sent": "And this particular ancestor.",
                    "label": 0
                },
                {
                    "sent": "OK, now what we're going to do is take this phylogenetic tree an now at each position along the HIV and each possible amino acid we're going to analyze the appearances of those amino acids across the different patients with this same phylogenetic.",
                    "label": 0
                }
            ]
        },
        "clip_22": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Tree, but we're going to take take the the structure of the phylogenetic tree and interpret it as a Bayes net or a directed acyclic graph.",
                    "label": 0
                },
                {
                    "sent": "So now these observe nodes just correspond to binary observations.",
                    "label": 0
                },
                {
                    "sent": "Do we see the amino acid or not at this particular position an these hidden nodes correspond to the evolution of this particular amino acid down through the evolutionary tree of the sequences, and we're going to use the length of the transitions.",
                    "label": 0
                },
                {
                    "sent": "In this phylogenetic tree to parameterize the conditional probability distributions associated with this with this Bayes net.",
                    "label": 0
                },
                {
                    "sent": "To do that, we're going to use what's called a continuous time Markov process.",
                    "label": 0
                },
                {
                    "sent": "Basically, we're saying that any at any small transition in time, there's a small probability that the amino acid will mutate from X to not X or from not X to X.",
                    "label": 0
                },
                {
                    "sent": "And since our variables are binary, this continuous time Markov process boils down to a very simple thing.",
                    "label": 0
                },
                {
                    "sent": "Namely, let's imagine that this node is not X and this and we ask the question, what's the probability that this node is X after its head length time T to evolve well in the continuous time Markov process, that probability increases exponentially to some asymptotes.",
                    "label": 0
                },
                {
                    "sent": "The asymptotes is the stationary distribution of X, which we call \u03c0, and the rate at which this probability changes as a function of length T is.",
                    "label": 1
                },
                {
                    "sent": "Governed by some exponential rate Lambda.",
                    "label": 0
                },
                {
                    "sent": "So with just two parameters we can describe all the conditional probability distributions in this Bayes net.",
                    "label": 0
                },
                {
                    "sent": "And given the observations at the leaves and given the structure and given these length length, these evolutionary length we can find say the maximum likelihood values of these parameters very simply with gradient methods or EM.",
                    "label": 0
                },
                {
                    "sent": "So that's Model 1 which says we can explain what we're seeing in terms of the amino acid at this particular position.",
                    "label": 1
                },
                {
                    "sent": "We can explain that data.",
                    "label": 0
                }
            ]
        },
        "clip_23": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "With the phylogeny alone.",
                    "label": 0
                },
                {
                    "sent": "The second model says.",
                    "label": 0
                },
                {
                    "sent": "Now we need both the phylogeny and we need to know about the patients HLA to explain this data.",
                    "label": 0
                },
                {
                    "sent": "So what happens here?",
                    "label": 0
                },
                {
                    "sent": "These nodes used to be the observed nodes in Model 1.",
                    "label": 0
                },
                {
                    "sent": "Those now become hidden variables and the hidden variables represent what you would expect.",
                    "label": 0
                },
                {
                    "sent": "This hidden variable represents what the amino acid in this patient would have been had there been no HLA pressure.",
                    "label": 0
                },
                {
                    "sent": "Now the actual observation the amino acid we actually see in the patient is a function of this hidden variable.",
                    "label": 0
                },
                {
                    "sent": "And the HLA of the patient.",
                    "label": 0
                },
                {
                    "sent": "So we characterize this probability distribution here with some parameters which are tide across all the different patients.",
                    "label": 0
                },
                {
                    "sent": "We assume that this HLA pressure is constant across all the patients, so we have a few parameters there and we have these two parameters.",
                    "label": 0
                },
                {
                    "sent": "Python, Lambda, given the observations.",
                    "label": 0
                },
                {
                    "sent": "Again we can use something like EM to find the maximum likelihood values of these parameters very easily OK.",
                    "label": 0
                }
            ]
        },
        "clip_24": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So those are our two models and again I want to emphasize we're doing this many, many times.",
                    "label": 0
                },
                {
                    "sent": "We're doing this analysis for each HLA.",
                    "label": 0
                },
                {
                    "sent": "Does the patient have HLA one or not?",
                    "label": 0
                },
                {
                    "sent": "Does the patient have HLA two or not so forth and we're doing this analysis for every position along HIV.",
                    "label": 0
                },
                {
                    "sent": "There's 3000 of 'em and then we're doing this analysis for every amino acid that we see at every possible position.",
                    "label": 0
                },
                {
                    "sent": "So for real data set, we're looking at hundreds of thousands to millions of tests here, so this brings us to the problem of what do you tell the biologist?",
                    "label": 0
                }
            ]
        },
        "clip_25": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "You do these analysis.",
                    "label": 0
                },
                {
                    "sent": "Well, you can tell the biologists look.",
                    "label": 0
                },
                {
                    "sent": "Here's here's here's one we found where the difference in log likelihoods is very high and they will kind of look at you funny when you tell them about log likelihoods.",
                    "label": 0
                },
                {
                    "sent": "You can say, well, I can take this difference in log likelihoods, which is supposed to be chi squared distributed with one degree of freedom.",
                    "label": 0
                },
                {
                    "sent": "And I can give you a P value and then of course you have to do corrections for multiple testing.",
                    "label": 0
                },
                {
                    "sent": "And if you use some standard method like Bonferroni on 100,000 tests.",
                    "label": 0
                },
                {
                    "sent": "You get absolutely nothing, or you can be Bayesian about it, can say, well, let's compute the posterior probability that that Association is present.",
                    "label": 0
                },
                {
                    "sent": "And rightly so, they question your analysis, because it turns out the answers you get with this sort of Bayesian analysis can be sensitive to the prior.",
                    "label": 0
                },
                {
                    "sent": "So if you can't justify the prior, you.",
                    "label": 0
                }
            ]
        },
        "clip_26": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Not justify the posterior.",
                    "label": 0
                },
                {
                    "sent": "I.",
                    "label": 0
                },
                {
                    "sent": "So what do biologists really want?",
                    "label": 0
                },
                {
                    "sent": "Well, what they really would like is to say, look, give me a list of the most likely associations such that you can promise me that at most 20%, let's say, are spurious.",
                    "label": 0
                },
                {
                    "sent": "That is due to chance, or maybe at most 10% or spurious, whatever they want, a list of associations, and they want to know how many of those are likely to be legitimate.",
                    "label": 0
                }
            ]
        },
        "clip_27": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And two folks, Benjamin Hochberg.",
                    "label": 0
                },
                {
                    "sent": "Recognize this general need quite awhile back in 1995 and they developed this false discovery rate, which I'll tell you about in a second, at which basically addresses this issue.",
                    "label": 0
                },
                {
                    "sent": "So imagine we have some statistical tests, and for simplicity, let's just think about P values.",
                    "label": 0
                },
                {
                    "sent": "We have some statistical tests that produces P values and we apply this statistical test to hundreds of thousands of different instances, as in in this problem that we have with HIV.",
                    "label": 0
                },
                {
                    "sent": "OK, so we define two quantities S of T, which are the S is the number of associations that we find if we look at all those associations with some P value less than T. And then we define F of T to be the number of those associations that are spurious that are due to chance.",
                    "label": 0
                },
                {
                    "sent": "OK, then Benjamin Hochberg define the false discovery rate, which is now function of this threshold T to be the expectation with respect to the true underlying distribution.",
                    "label": 0
                },
                {
                    "sent": "The data of the ratio of FT to SFT.",
                    "label": 0
                },
                {
                    "sent": "Now we don't know the true underlying distribution of the data, so it's kind of hard to take this expectation, but they came up with a method for estimating this expectation.",
                    "label": 0
                },
                {
                    "sent": "Unfortunately, that method was rather complicated.",
                    "label": 0
                }
            ]
        },
        "clip_28": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And it wasn't until about eight years later that story and tips, Ronnie came up with a very simple way to estimate this false discovery rate.",
                    "label": 0
                },
                {
                    "sent": "And this is the approach that we use when we apply it to the graphical modeling application that I just described.",
                    "label": 0
                },
                {
                    "sent": "So let me go through this briefly.",
                    "label": 0
                },
                {
                    "sent": "Here's the false discovery rate as defined by.",
                    "label": 0
                },
                {
                    "sent": "Mountain hope work and instead of taking the expectation, the ratio, we're going to take the ratio of the expectations there.",
                    "label": 0
                },
                {
                    "sent": "That's often a good approximation under many circumstances, and now to estimate this denominator, we're just going to use the actual number of associations that we found on our data.",
                    "label": 1
                },
                {
                    "sent": "This is supposed to be expectation with respect to the true distribution.",
                    "label": 0
                },
                {
                    "sent": "Let's just use the actual number that we found an enumerator.",
                    "label": 0
                },
                {
                    "sent": "What we want is the expectation of the number of associations that are spurious.",
                    "label": 1
                },
                {
                    "sent": "We're going to do is generate a null distribution, a distribution where we know there are no associations.",
                    "label": 0
                },
                {
                    "sent": "Apply our method to that data and just count up how many associations we get.",
                    "label": 0
                },
                {
                    "sent": "That's an approximation.",
                    "label": 0
                },
                {
                    "sent": "But as you'll see, it's it works quite well in practice in many circumstances.",
                    "label": 0
                },
                {
                    "sent": "So then you just take the ratio of these two and you've got your false discovery right?",
                    "label": 0
                },
                {
                    "sent": "So let's go through this again with a specific example.",
                    "label": 0
                },
                {
                    "sent": "Suppose we have we choose a cutoff AP value cutoff of .01, and we imply that P value to hundreds of thousands of tests.",
                    "label": 0
                },
                {
                    "sent": "And let's suppose we see 40 associations that come back with a P value less than .01.",
                    "label": 0
                },
                {
                    "sent": "Now we generate null data that looks a lot like.",
                    "label": 0
                },
                {
                    "sent": "Are real data, but such that it has no real associations in it and we apply our same graphical modeling approach to that.",
                    "label": 0
                },
                {
                    "sent": "And let's say after we run several different models we find maybe just eight associations on average that come back with a P value less than this cutoff.",
                    "label": 0
                },
                {
                    "sent": "So in this case the false discovery rate is just the ratio 8 to 40, which is 20%.",
                    "label": 0
                },
                {
                    "sent": "Now if 20% is too high for the biologists, you can lower the P value cutoff.",
                    "label": 0
                },
                {
                    "sent": "Get a get a shorter list with a with a smaller false discovery rate.",
                    "label": 0
                },
                {
                    "sent": "The false discovery rates too high.",
                    "label": 0
                },
                {
                    "sent": "You can raise the P value cutoff, get a longer list of associations with a larger false discovery rate.",
                    "label": 0
                },
                {
                    "sent": "That's all there is to it.",
                    "label": 0
                }
            ]
        },
        "clip_29": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Very very straightforward.",
                    "label": 0
                },
                {
                    "sent": "Now how do we generate these null distributions?",
                    "label": 0
                },
                {
                    "sent": "Well, in some cases it's difficult, but in our case it's very easy.",
                    "label": 0
                },
                {
                    "sent": "We want a distribution that looks just like the real data, but where there's no real associations between HLA and the amino acid that we see in the HIV protein.",
                    "label": 0
                },
                {
                    "sent": "So here's our data for HLA.",
                    "label": 0
                },
                {
                    "sent": "Here's our data for amino acid.",
                    "label": 0
                },
                {
                    "sent": "We just permute the indices of one of these tables, and now we're guaranteed, but we have data that looks very much like the original data, and we're guaranteed there's no true associations.",
                    "label": 0
                },
                {
                    "sent": "And in that data will be associations there by accident, but they will be spurious.",
                    "label": 0
                }
            ]
        },
        "clip_30": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "OK, so first thing we did is we tried this with synthetic data to make sure it made sense.",
                    "label": 0
                },
                {
                    "sent": "So we generated synthetic data that looked a lot like our real data.",
                    "label": 0
                },
                {
                    "sent": "I won't go into the details of that.",
                    "label": 0
                },
                {
                    "sent": "Then we apply this graphical modeling FDR approach to that data and then we and we did this for various P value cutoff.",
                    "label": 0
                },
                {
                    "sent": "So we get different false discovery rates and then we measured the false positives that we saw.",
                    "label": 0
                },
                {
                    "sent": "We saw we plotted the false positives that we actually saw versus the estimated false discovery rates that we computed with this story and tips Ronnie.",
                    "label": 0
                }
            ]
        },
        "clip_31": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Method OK, when you do that, you get actually fairly good agreement.",
                    "label": 0
                },
                {
                    "sent": "This is the estimated false discovery rate and this is the actual false positive rate that you see in the data.",
                    "label": 0
                },
                {
                    "sent": "Again, it's synthetic data, so we know where the real false positives are.",
                    "label": 0
                }
            ]
        },
        "clip_32": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So encouraged by that we went back to the original study that Simon will all published in science.",
                    "label": 0
                },
                {
                    "sent": "We used a slightly updated version of his data, applied a sensually the same method that he did to this data, and found roughly 80 significant associations.",
                    "label": 0
                },
                {
                    "sent": "This is a data set on roughly 100 patients and again the associations didn't coincide very well with the epitopes that were known at the time.",
                    "label": 0
                },
                {
                    "sent": "And now we took our graphical modeling approach with the FDR method, applied it to the same data and we only found eight associations at a false discover rate of .2.",
                    "label": 0
                },
                {
                    "sent": "And the biologist went back and did some validation studies on these associations, and sure enough, six out of eight of them were experimentally validated, and that's certainly consistent with this false discovery rate of .2, so.",
                    "label": 0
                },
                {
                    "sent": "The good news is that we kind of found the bug with the statistics and fixed it.",
                    "label": 0
                },
                {
                    "sent": "But the bad news is my gosh, there's not very many associations here.",
                    "label": 0
                },
                {
                    "sent": "Maybe the cellular arm of the immune system doesn't exert a very strong influence on HIV, but of course there's a missing.",
                    "label": 0
                }
            ]
        },
        "clip_33": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Part of the story here, which is when you generate a list of a given false with given false discovery rate.",
                    "label": 0
                },
                {
                    "sent": "How many of the true associations are you missing?",
                    "label": 0
                },
                {
                    "sent": "What's the false negative rate?",
                    "label": 0
                },
                {
                    "sent": "And to do that we just did a sort of a standard power study where you generate synthetic data, apply your approach, and then plot false negative rate as a function of.",
                    "label": 0
                }
            ]
        },
        "clip_34": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "The sample size when we do that, you get a curve that looks like this, and sure enough, for sample size is similar to the data set in the science paper analysis we're missing, we find that we're missing over 90% of all the true associations.",
                    "label": 0
                }
            ]
        },
        "clip_35": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Now I got lucky.",
                    "label": 0
                },
                {
                    "sent": "I did a mini sabbatical at mass general last summer.",
                    "label": 0
                },
                {
                    "sent": "And just as I arrived, a postdoc arrived and she had the perfect data set.",
                    "label": 0
                },
                {
                    "sent": "She had about 600 patients, patients where she knew their HLA types and she knew their HIV sequences and so we applied this approach to that larger data set and sure enough, we found lots and lots of associations.",
                    "label": 0
                },
                {
                    "sent": "An at this sample size, we estimate that we're still missing about half the Association, so you should really multiply these numbers roughly by two so you can see there's a lot of associations here.",
                    "label": 0
                },
                {
                    "sent": "For example, in the protein.",
                    "label": 0
                },
                {
                    "sent": "Now these are different proteins in HIV, protease, RTF for the protein NEF, there is well over.",
                    "label": 0
                },
                {
                    "sent": "Others about.",
                    "label": 0
                },
                {
                    "sent": "270 two 180 or so associations found enough and there's only 206 positions in the protein, so of course there's.",
                    "label": 0
                },
                {
                    "sent": "These associations are also HLA dependent, so there's still.",
                    "label": 0
                },
                {
                    "sent": "I mean, the bottom line is there's a lot of associations here, and this has started to convince people that there really is hope for a cellular vaccine for HIV, because the obviously the cellular Army immune system exerts very strong pressure on HIV.",
                    "label": 0
                },
                {
                    "sent": "I should also say that.",
                    "label": 0
                },
                {
                    "sent": "The biologist went back and did some validation studies on these associations, and again they found that about 80% of these made sense biologically and again the false discovery rate that we used to do this was .2.",
                    "label": 0
                },
                {
                    "sent": "So those numbers are consistent.",
                    "label": 0
                }
            ]
        },
        "clip_36": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Alright.",
                    "label": 0
                },
                {
                    "sent": "Now, since we've developed this method, biologists have started using it and finding out all sorts of interesting things about HIV.",
                    "label": 0
                },
                {
                    "sent": "I'd like to tell you about one thing that they've learned.",
                    "label": 0
                },
                {
                    "sent": "I should say they used other approaches in addition to our approach to learn this, but it's a very exciting observation, and it has profound implications for HIV vaccine design.",
                    "label": 0
                },
                {
                    "sent": "And that is, we've discovered that HIV has both good epitopes and bad epitopes.",
                    "label": 0
                },
                {
                    "sent": "Now a good epitope.",
                    "label": 0
                },
                {
                    "sent": "Is sort of the way I described it earlier.",
                    "label": 0
                },
                {
                    "sent": "You've got the immune system attacking HIV.",
                    "label": 0
                },
                {
                    "sent": "HIV has to mutate away to avoid that attack, and in so doing it either kills itself or its weakened.",
                    "label": 0
                },
                {
                    "sent": "That's a good epitope.",
                    "label": 0
                },
                {
                    "sent": "A bad epitope is a situation where the immune system attacks HIV, HIV mutates, and it survives quite happily, but at the expense of the immune system.",
                    "label": 0
                },
                {
                    "sent": "Immune system is now wasted its energy attacking HIV in this position to no good.",
                    "label": 0
                },
                {
                    "sent": "So it turns out HIV is throwing out.",
                    "label": 0
                },
                {
                    "sent": "We thank all these decoys, lots and lots of bad epitope decoys.",
                    "label": 0
                },
                {
                    "sent": "Wasting the time of the immune system so that in the hopes that it won't.",
                    "label": 0
                },
                {
                    "sent": "Add immune system will not have enough energy left to attack the good epitopes.",
                    "label": 0
                },
                {
                    "sent": "And so with this insight, it sort of becomes clear how you might want to design A vaccine.",
                    "label": 0
                },
                {
                    "sent": "What you want to do is identify the good epitopes, put those good epitopes in a vaccine that would then train your immune system to recognize those epitopes ahead of you being infected.",
                    "label": 0
                },
                {
                    "sent": "And by all means avoiding the bad epitopes in the vaccine.",
                    "label": 0
                },
                {
                    "sent": "You do not want to put these bad epitopes in the vaccine, and it turns out Ascentia Lee all the vaccine designs that we've seen so far have not paid attention to this distinction.",
                    "label": 0
                },
                {
                    "sent": "And it's very likely that there's bad epitopes in these vaccine designs, which may be an explanation for why they haven't worked.",
                    "label": 0
                },
                {
                    "sent": "So this is all very encouraging, but it brings us to the second application.",
                    "label": 0
                }
            ]
        },
        "clip_37": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Now I'm going to talk about which is where are these epitopes?",
                    "label": 0
                },
                {
                    "sent": "Now let me remind you that an epitope is really a relation.",
                    "label": 0
                },
                {
                    "sent": "It has to do with whether a peptide a particular, let's say 9 amino acid long peptide binds inside of a particular HLA molecule.",
                    "label": 0
                },
                {
                    "sent": "So we've got to find both the peptide in the HLA well.",
                    "label": 0
                },
                {
                    "sent": "Finding the peptides is fairly easy because epitopes are going to exist either in regions where we found our HLA HIV associations that I just showed you, or in regions where HIV doesn't mutate at all.",
                    "label": 0
                },
                {
                    "sent": "So those are the likely candidates for the peptides.",
                    "label": 0
                },
                {
                    "sent": "Then we have to find the HLA alleles that go with those peptides to make the epitopes and this is going to be a little tricky 'cause there's hundreds of different types of HLA molecules that's rather expensive to do this in the lab, and so the subject of this work that I'm going to talk about is given a peptide.",
                    "label": 0
                },
                {
                    "sent": "How do you figure out which hlas make that peptide and epitope?",
                    "label": 0
                },
                {
                    "sent": "And again we need to know which HLA's do this because we want to build a vaccine for a population of people where there's a distribution of HLA types and we want to make sure that this vaccine.",
                    "label": 0
                },
                {
                    "sent": "Can cover a lot of these.",
                    "label": 0
                }
            ]
        },
        "clip_38": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "HLA types in the population.",
                    "label": 0
                },
                {
                    "sent": "So here's how we do it.",
                    "label": 0
                },
                {
                    "sent": "This is work with Christian Brander and Nicole from at mass general.",
                    "label": 0
                },
                {
                    "sent": "We take a peptide.",
                    "label": 0
                },
                {
                    "sent": "We manufacture peptide that we think might be an epitope and we mix it with the blood of several different patients, maybe 100 different patients.",
                    "label": 0
                },
                {
                    "sent": "Then if there is a reaction in this test tube, it's called an elispot reaction.",
                    "label": 0
                },
                {
                    "sent": "If we see this reaction, it means that very likely one of the six HLA types of this patient is responsible for this being an epitope.",
                    "label": 0
                },
                {
                    "sent": "This peptide being an epitope.",
                    "label": 0
                },
                {
                    "sent": "Now we don't know which of the six.",
                    "label": 0
                }
            ]
        },
        "clip_39": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "But since we have observations across many patients, we can tease out what the HLA types are.",
                    "label": 0
                },
                {
                    "sent": "For example, if these two patients react and none of the other patients do well, we see that these two patients have be 58 in common, but the rest of the patients don't, so it's very likely that be 58 in combination with this peptide.",
                    "label": 0
                }
            ]
        },
        "clip_40": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Is an epitope.",
                    "label": 0
                },
                {
                    "sent": "Of course, that's oversimplification.",
                    "label": 0
                },
                {
                    "sent": "There are complications or false negatives.",
                    "label": 0
                },
                {
                    "sent": "There's false positives.",
                    "label": 0
                },
                {
                    "sent": "Sometimes you can have more than one HLA being responsible for a particular peptide being an epitope.",
                    "label": 0
                },
                {
                    "sent": "So how do you get partial credit?",
                    "label": 0
                },
                {
                    "sent": "This just shows how messy it can get.",
                    "label": 0
                },
                {
                    "sent": "This row of patients here.",
                    "label": 0
                },
                {
                    "sent": "Each column corresponds to a patient.",
                    "label": 0
                },
                {
                    "sent": "Patients reacted.",
                    "label": 0
                },
                {
                    "sent": "To a particular peptide, these patients didn't react to a particular peptide, and the correct solution, the HLA's, that are responsible for this peptide being epitope, are 823 and read a two and blue and C2 in green, so you can see there's false positives here.",
                    "label": 0
                },
                {
                    "sent": "We've got a patient that has none of these hlas Bhutan.",
                    "label": 0
                },
                {
                    "sent": "They they do react and here we have a patient that has some of these HLA levels that are responsible for this peptide being epitope, but they don't react.",
                    "label": 0
                },
                {
                    "sent": "OK, so.",
                    "label": 0
                }
            ]
        },
        "clip_41": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "It's a messy problem, but in this community that doesn't.",
                    "label": 0
                },
                {
                    "sent": "That doesn't stop us in this case.",
                    "label": 0
                },
                {
                    "sent": "Simple graphical model addresses the uncertainty.",
                    "label": 0
                },
                {
                    "sent": "Here we can use a bipartite directed acyclic graph where the upper level corresponds to whether the patient has the HLA or not.",
                    "label": 0
                },
                {
                    "sent": "The lower level represents whether the patient reacts to a particular peptide or not.",
                    "label": 0
                },
                {
                    "sent": "This is reacting to peptide one reacting to peptide two and so forth, and then to deal with the multiple credit problem we just use a noisy or distribution here.",
                    "label": 0
                },
                {
                    "sent": "So if a particular peptide.",
                    "label": 0
                },
                {
                    "sent": "Can react with both HLA one and HLA three.",
                    "label": 0
                },
                {
                    "sent": "We increase the probability that it's going to react according to a noisy or model which when you talk to the biologists they say that makes sense.",
                    "label": 0
                },
                {
                    "sent": "Now what's an epitope here?",
                    "label": 0
                },
                {
                    "sent": "Well, what we're going to do is take the data and do sort of standard Bayes net learning, Bayes net structure, learning an.",
                    "label": 0
                },
                {
                    "sent": "Whenever we find an arc here, well that corresponds.",
                    "label": 0
                },
                {
                    "sent": "There being an epitope in arc means that having this HLA influences the probability that you're going to react and so basically.",
                    "label": 1
                },
                {
                    "sent": "An arc corresponds to there being an epitope.",
                    "label": 0
                }
            ]
        },
        "clip_42": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "The presence of an art corresponds to there being an epitope.",
                    "label": 0
                },
                {
                    "sent": "So now let's go back to this problem with the biologists.",
                    "label": 0
                },
                {
                    "sent": "Want I tried showing him the Bayes net you get from structure learning, which is the most likely network structure and they kind of look at you funny and they say no, we don't trust that based on that, how many of these arcs are legit legitimate?",
                    "label": 0
                },
                {
                    "sent": "So we come back to this false discovery rate problem.",
                    "label": 0
                },
                {
                    "sent": "We want to list of epitopes, IE list of arcs in the graph and we want to know how many of those arcs are due to chance.",
                    "label": 0
                }
            ]
        },
        "clip_43": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Well, it turns out that this very simple method.",
                    "label": 0
                },
                {
                    "sent": "That story and tips Ronnie developed for estimating the false discovery rate can be applied very easily to this problem of Bayes net or directed acyclic graph model learning, and this is some work that I've done with Jennifer Liz Garton.",
                    "label": 0
                },
                {
                    "sent": "I'm just going to give you the bare Bones story here.",
                    "label": 0
                },
                {
                    "sent": "We're going to present this in detail at UI in just a few weeks, so here's how it goes.",
                    "label": 0
                },
                {
                    "sent": "When we were given some data.",
                    "label": 0
                },
                {
                    "sent": "And we have some structure learning algorithm A.",
                    "label": 0
                },
                {
                    "sent": "Any algorithm you want any algorithm for learning structure that you like and what we want to output is obviously the Bayes net and also an estimate of how many arcs.",
                    "label": 0
                },
                {
                    "sent": "Net based net are Spurs.",
                    "label": 0
                },
                {
                    "sent": "How many of those arcs are due to chance?",
                    "label": 0
                },
                {
                    "sent": "Now to make things easy we're going to do all the simple assumptions.",
                    "label": 0
                },
                {
                    "sent": "We're going to assume that the node parameters are independent and then we have complete data so we can learn the parents of each node separately and we're going to assume the node ordering is.",
                    "label": 0
                },
                {
                    "sent": "The note ordering is known.",
                    "label": 0
                },
                {
                    "sent": "That's true for the problem we have that I just showed you and also makes it very easy to decide whether an arc is spurious or not.",
                    "label": 0
                },
                {
                    "sent": "So let's stick with those.",
                    "label": 0
                },
                {
                    "sent": "The simple case and the way we compute the false discovery rate is just analogous, very analogous to what we did in the first problem.",
                    "label": 0
                },
                {
                    "sent": "First of all, we take our algorithm and apply it to the real data, and we just count how many arcs we get.",
                    "label": 0
                },
                {
                    "sent": "Then we take our real data and generate null distributions from that data distributions where we know there are no real.",
                    "label": 0
                },
                {
                    "sent": "Associations there and then we feed that data to our model selection algorithm and see how many arcs it hallucinates.",
                    "label": 0
                },
                {
                    "sent": "OK, so we got the expected number of arcs under the null and we get that by averaging over a bunch of nulls to get rid of noise in the estimate and we just divide that by the actual number of arcs that we see on the real data.",
                    "label": 0
                },
                {
                    "sent": "That's our false discovery rate.",
                    "label": 0
                },
                {
                    "sent": "So the 1st.",
                    "label": 0
                }
            ]
        },
        "clip_44": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Question is, how well does that work?",
                    "label": 0
                },
                {
                    "sent": "Well, here's an example on synthetic data.",
                    "label": 0
                },
                {
                    "sent": "We generated some data that looked a lot like the original data.",
                    "label": 0
                },
                {
                    "sent": "And we plot here estimated false discovery rate as a function of the actual fraction of false positives in the data, and you can see that at least 4 lower false discovery rates 10% twenty percent 30% you get quite a good agreement, and this is the range where biologists are interested anyway.",
                    "label": 0
                },
                {
                    "sent": "Relatively small false discovery rates, so that's good news.",
                    "label": 0
                },
                {
                    "sent": "You do see the curve peel away here, though we think we understand why that occurs, and we think we have a solution to that.",
                    "label": 0
                },
                {
                    "sent": "But I won't go through the details there.",
                    "label": 0
                },
                {
                    "sent": "If you're interested, come to UA or obviously come.",
                    "label": 0
                }
            ]
        },
        "clip_45": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And talk to me after the talk.",
                    "label": 0
                },
                {
                    "sent": "So now we've got this approach, which looks pretty good on synthetic data.",
                    "label": 0
                },
                {
                    "sent": "Let's go back to the real data.",
                    "label": 0
                },
                {
                    "sent": "Going into this there 169 HIV epitopes known.",
                    "label": 0
                },
                {
                    "sent": "And we took some real data, about 100 patients and measured about 100 peptides and a false discovery rate of .3.",
                    "label": 0
                },
                {
                    "sent": "We found 118 additional additional epitopes now it's very difficult to verify these epitopes, so so far they've only verified seven out of seven, which is consistent with this false discovery rate.",
                    "label": 0
                },
                {
                    "sent": "But they have a long way to go in verifying these.",
                    "label": 0
                },
                {
                    "sent": "But anyway, one of the things we learned, assuming assuming this list is correct, one of the things that we've learned that's interesting for the biologist is.",
                    "label": 0
                },
                {
                    "sent": "Going into this study, it was thought that if you have a single epitope, maybe 1, maybe two HLA's, or if you had a single peptide.",
                    "label": 0
                },
                {
                    "sent": "Excuse me, maybe one or two hlas would make that peptide an epitope.",
                    "label": 0
                },
                {
                    "sent": "But with this study, it looks like more like it looks more like 3456.",
                    "label": 0
                },
                {
                    "sent": "Hlas will all make the same peptide and epitope and that again is very good news for vaccine design because you want to put.",
                    "label": 0
                },
                {
                    "sent": "In a vaccine epitopes that cover a broad range of HLA types, and here we're learning that there often can be more than one.",
                    "label": 0
                },
                {
                    "sent": "In fact, up to six HLA's that can present a particular peptide as being an app.",
                    "label": 0
                }
            ]
        },
        "clip_46": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Tub so that's about it.",
                    "label": 0
                },
                {
                    "sent": "And graphical models are helping with the design of HIV vaccine using graphical models, we've learned that HIV is highly vulnerable to the cellular arm of the immune system.",
                    "label": 0
                },
                {
                    "sent": "We're finding and we're using graphical models defined epitopes to include in the vaccine, and Conversely, in the process of developing these graphical model approaches for the biologists, I've learned something very important that they when you give them a graphical model, they want to know how many of those arcs are due to chance and using the false discovery rate.",
                    "label": 0
                },
                {
                    "sent": "We can give him an estimate of that quantity, and finally we've the biologists are starting to use these tools.",
                    "label": 0
                },
                {
                    "sent": "We put them online.",
                    "label": 0
                },
                {
                    "sent": "We also put the source code online so people can look at these methods and hopefully enhance them.",
                    "label": 0
                },
                {
                    "sent": "So if you're interested, the tools are available at Microsoft.",
                    "label": 0
                },
                {
                    "sent": "Com dance.",
                    "label": 0
                }
            ]
        },
        "clip_47": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Slash science and finally, I want to thank.",
                    "label": 0
                },
                {
                    "sent": "Several folks, Betty corporate Amway but Acharia at Los Alamos National labs.",
                    "label": 0
                },
                {
                    "sent": "We had some great discussions about how use phylogeny to correct for finding these associations in the data and also of course the biologist themselves.",
                    "label": 0
                },
                {
                    "sent": "They're very clever.",
                    "label": 0
                },
                {
                    "sent": "They come up with these brilliant hypothesis to test, and of course for the data that they provided.",
                    "label": 0
                },
                {
                    "sent": "Thank you very much.",
                    "label": 0
                },
                {
                    "sent": "Thanks for questions.",
                    "label": 0
                },
                {
                    "sent": "Yes.",
                    "label": 0
                },
                {
                    "sent": "Do you wanna pass a Mike?",
                    "label": 0
                },
                {
                    "sent": "The Association between.",
                    "label": 0
                },
                {
                    "sent": "How does it?",
                    "label": 0
                },
                {
                    "sent": "How does it help the vaccine design design such that it's?",
                    "label": 0
                },
                {
                    "sent": "I mean it's personalized to specific individuals because, well, it when you find first of all, if you find an Association, there's gotta be an epitope there somewhere.",
                    "label": 0
                },
                {
                    "sent": "So then you can use the second application I showed you.",
                    "label": 0
                },
                {
                    "sent": "Or other more expensive methods to find that actual epitope.",
                    "label": 0
                },
                {
                    "sent": "Now you've got a peptide that you conclude in.",
                    "label": 0
                },
                {
                    "sent": "You can include in the vaccine that will make at least the people with that HLA type will help them fight the virus if they get infected.",
                    "label": 0
                },
                {
                    "sent": "But as I just showed you, that one peptide may also be appropriate for three or four other types of HLA, so you get a little bit broader coverage.",
                    "label": 0
                },
                {
                    "sent": "So the trick is to find some epitopes that tend to have broad coverage across the HLA's good epitopes as opposed to the bad ones and get them into the.",
                    "label": 0
                },
                {
                    "sent": "Vaccine.",
                    "label": 0
                },
                {
                    "sent": "So it's not a vaccine is not going to consist of 1 epitope, it's going to consist of numerous epitopes.",
                    "label": 0
                },
                {
                    "sent": "Hopefully a small number.",
                    "label": 0
                },
                {
                    "sent": "The smaller the vaccine, the easier it is to get into your body.",
                    "label": 0
                },
                {
                    "sent": "There's less chances for bad reactions and so forth, so there's going to be this tradeoff between how many people we can cover, what fraction of the population we can cover, and how, how long this vaccine is going to be.",
                    "label": 0
                },
                {
                    "sent": "I should say there's as if Salon HLA types, so it's not like.",
                    "label": 0
                },
                {
                    "sent": "There's 1 /, 100 of each type of a baby, and see some types are much more common than the other, so using the Zips law we can get pretty far down the tail covering some of covering the top 20% of hlas let's.",
                    "label": 0
                },
                {
                    "sent": "So I I thought it was wonderful that you had both for the false discovery rate in the 1st.",
                    "label": 0
                },
                {
                    "sent": "First both false memory, right analog power for that way on the second problem is that you do that, yeah?",
                    "label": 0
                },
                {
                    "sent": "We we I can't remember now I know is over 50%.",
                    "label": 0
                },
                {
                    "sent": "But yeah, there's a lot of epitopes out there left to be discovered.",
                    "label": 0
                },
                {
                    "sent": "We need some more data.",
                    "label": 0
                },
                {
                    "sent": "Shoulders.",
                    "label": 0
                },
                {
                    "sent": "Overestimates correlation.",
                    "label": 0
                },
                {
                    "sent": "They can either overestimate or underestimate, depending on what the phylogeny phylogenetic structure.",
                    "label": 0
                },
                {
                    "sent": "In this case, the overestimations.",
                    "label": 0
                },
                {
                    "sent": "We did find some false negatives though too.",
                    "label": 0
                },
                {
                    "sent": "So in the original data they missed some of the associations that we picked up.",
                    "label": 0
                },
                {
                    "sent": "Coalition.",
                    "label": 0
                },
                {
                    "sent": "Approximately.",
                    "label": 0
                },
                {
                    "sent": "Actually.",
                    "label": 0
                },
                {
                    "sent": "Yeah.",
                    "label": 0
                },
                {
                    "sent": "This is very quickly.",
                    "label": 0
                },
                {
                    "sent": "Oh well it can.",
                    "label": 0
                },
                {
                    "sent": "It have to do.",
                    "label": 0
                },
                {
                    "sent": "It.",
                    "label": 0
                },
                {
                    "sent": "Can have to do with geography.",
                    "label": 0
                },
                {
                    "sent": "For example different parts of Africa.",
                    "label": 0
                },
                {
                    "sent": "Let's say have different distributions of HLA type and different parts of Africa also have different HIV vaccines.",
                    "label": 0
                },
                {
                    "sent": "Just because the spread tends to be local so that actually isn't the explanation for all of the Association or for all of the overestimation.",
                    "label": 0
                },
                {
                    "sent": "But it is an explanation for a good chunk of the overestimation.",
                    "label": 0
                },
                {
                    "sent": "There's one illegal, in particular at C 1701.",
                    "label": 0
                },
                {
                    "sent": "Which occurs in certain regions which has this certain set of HIV sequences and that was responsible for vast large number of these false or spurious associations.",
                    "label": 0
                },
                {
                    "sent": "So in the second part of the talk, when you when you discuss epitopes, I believe you mean would have it also only what we want.",
                    "label": 0
                },
                {
                    "sent": "We want to find all the epitopes and then we have to.",
                    "label": 0
                },
                {
                    "sent": "There's a separate procedure you to to decide whether it's a good epitope.",
                    "label": 0
                },
                {
                    "sent": "Could it be possible that a certain epitope is good modular, certain natural rights and back orders from others?",
                    "label": 0
                },
                {
                    "sent": "Because that could be quite noticed.",
                    "label": 0
                },
                {
                    "sent": "It's quite possible.",
                    "label": 0
                },
                {
                    "sent": "In that case you just don't put it in the vaccine.",
                    "label": 0
                },
                {
                    "sent": "So you have to give up some of the benefits of the epitope for some part of the population.",
                    "label": 0
                },
                {
                    "sent": "So are there any lessons here?",
                    "label": 0
                },
                {
                    "sent": "Biological applications.",
                    "label": 0
                },
                {
                    "sent": "Well, yeah, I've been talking to voices Goldsmith recently and he's doing applications from Microsoft involving systems maintenance, and he's come across exactly the same problem, which is the people he's worked with when you show them a Bayes net, they don't trust it.",
                    "label": 0
                },
                {
                    "sent": "They want to know how many of the arcs are just hallucinated, and he's now trying this approach in that environment, and I think generally this is something that's bothered me for years.",
                    "label": 0
                },
                {
                    "sent": "Anyway, I.",
                    "label": 0
                },
                {
                    "sent": "People have throughout the years when I've showed them analysis from time to time, they've raised the question, you know, well, how can you?",
                    "label": 0
                },
                {
                    "sent": "How confident can I be in this structure?",
                    "label": 0
                },
                {
                    "sent": "Give me some measures that I can I can wrap my head around and I've never really been able to do that satisfactorily.",
                    "label": 0
                },
                {
                    "sent": "To know, I think so I think it's going to have lots of applications.",
                    "label": 0
                },
                {
                    "sent": "Answer my question.",
                    "label": 0
                },
                {
                    "sent": "I did the biologists wrong grumbling at here, no?",
                    "label": 0
                },
                {
                    "sent": "No.",
                    "label": 0
                },
                {
                    "sent": "Also, the great give additional new information, so it definitely gives additional new information.",
                    "label": 0
                },
                {
                    "sent": "They were right on the money, you know.",
                    "label": 0
                },
                {
                    "sent": "Shame.",
                    "label": 0
                },
                {
                    "sent": "Shame on me for not having dealt with this before talking with them, but in working with them it just became absolutely clear that they would not trust anything I said and less.",
                    "label": 0
                },
                {
                    "sent": "I provided them with some measures like this.",
                    "label": 0
                },
                {
                    "sent": "I think so.",
                    "label": 0
                },
                {
                    "sent": "You used to be a Bayesian.",
                    "label": 0
                },
                {
                    "sent": "What happened?",
                    "label": 0
                },
                {
                    "sent": "Ask like I still use whatever works is is what I am so you know I'm using Bayesian techniques to build the structure in the 1st place.",
                    "label": 0
                },
                {
                    "sent": "But yes I'm using frequentist methods to decide how many of those are extra spurious it works.",
                    "label": 0
                },
                {
                    "sent": "Thanks for noticing.",
                    "label": 0
                },
                {
                    "sent": "So in the first application, your model that HLA executive pressure on the observed variables only doesn't age legs or pressure.",
                    "label": 0
                },
                {
                    "sent": "Absolutely absolutely.",
                    "label": 0
                },
                {
                    "sent": "Maybe I should let me get to that slide.",
                    "label": 0
                },
                {
                    "sent": "That's a very good question.",
                    "label": 0
                },
                {
                    "sent": "Sex.",
                    "label": 0
                }
            ]
        },
        "clip_48": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Yes, or is it here?",
                    "label": 0
                },
                {
                    "sent": "OK, so isn't there HLA pressure going on here too?",
                    "label": 0
                },
                {
                    "sent": "Absolutely, but this transition supposedly represents hundreds of transmissions from one patient to the next.",
                    "label": 0
                },
                {
                    "sent": "An one patient is going to have the HLA, the next patient is not going to have the HLA, so roughly on average you're going to characterize this transition with some stationary distribution and some exponential rate of mutation.",
                    "label": 0
                },
                {
                    "sent": "Which is going to vary depending on how much HLA influences there.",
                    "label": 0
                },
                {
                    "sent": "So because we're fitting this model including the pion Lambda parameters, given the data that we see, we think at least to a first approximation that we're taking that into account in a reasonable way.",
                    "label": 0
                },
                {
                    "sent": "Now, if I knew if I knew the pedigree of of the HIV infections this person gave it to this person, which gave it to that person, then I could build a much better Bayes net which represented the HLA influences all along the way.",
                    "label": 0
                },
                {
                    "sent": "Can I ask a question just following up?",
                    "label": 0
                },
                {
                    "sent": "Is there in one 5 number for each locus absolutely for every HLA, for every amino acid for every position?",
                    "label": 0
                },
                {
                    "sent": "Treating no no.",
                    "label": 0
                },
                {
                    "sent": "We still have time for one or two more.",
                    "label": 0
                },
                {
                    "sent": "Did you really provided an unordered set of associations to biologists or you know they like they like to know which ones are most likely and we just sort them by P value?",
                    "label": 0
                },
                {
                    "sent": "It's at the top after after you get some experimental.",
                    "label": 0
                },
                {
                    "sent": "Oh, the ones near the top.",
                    "label": 0
                },
                {
                    "sent": "I mean you can build false to list with different false discovery rates and the ones at the top survive.",
                    "label": 0
                },
                {
                    "sent": "Even small false discovery rates.",
                    "label": 0
                },
                {
                    "sent": "And sure enough, those are the ones that hire you up on the list.",
                    "label": 0
                },
                {
                    "sent": "The more likely you are they were validated by the biologists, definitely.",
                    "label": 0
                },
                {
                    "sent": "One last question.",
                    "label": 0
                },
                {
                    "sent": "What is the best value?",
                    "label": 0
                },
                {
                    "sent": "The smallest P value.",
                    "label": 0
                },
                {
                    "sent": "OG 10 -- 17 or something like that, yeah?",
                    "label": 0
                },
                {
                    "sent": "OK, well thank you very much.",
                    "label": 0
                },
                {
                    "sent": "Inside",
                    "label": 0
                }
            ]
        }
    }
}